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Association of Frailty Indicators and Health Care Related Outcomes 
In Severe Chronic Obstructive Pulmonary Disease 
By 








Background: COPD is a chronic disease that not only has a high prevalence but is 
associated with a significant reduced health- related quality of life (HRQoL). Frailty is a 
prevalent health problem of older people with adverse outcomes. The purpose of this 
study was to examine demographic characteristics, clinical characteristics, physical 
frailty indicators, and psychological frailty indicators and their impact on health care 
outcomes (health related quality of life, death, and utilization of health care resources) in 
people with severe COPD over time. Methods: The research was a secondary data 
analysis of 610 severe COPD individuals. HRQol was assessed using the St. George’s 
Respiratory Questionnaire (SGRQ), death was all cause mortality, and health care 




Results: Age, gender, education, endurance, balance, mobility, coping, and depression 
were significant (p = <.05) predictors in the models of HRQOL. The total variance 
explained by the baseline model (demographic, physical, and psychological frailty 
indicators) was 36%, F (16, 567) = 20.31, p = < .001.  The mean survival time for lower 
frail individuals was 7.4 years compared to 4.7 years for higher frail individuals (p = 
<.001). Gender, income, education, smoking history, depression, PaO2 (RA), DLCO, 
TLC, RV, FEV1, endurance, nutrition, education,  and balance were significant (p = <.05) 
predictors in the models of health care utilization.  
Conclusions: Mobility and coping were significant indicators (p = <.001) over time 
predicting quality of life. These indicators should be included in frailty models. Higher 
frailty was associated with higher mortality. Those with higher COPD disease severity 







CHAPTER ONE: INTRODUCTION 
It is predicted that in the United States those age 65 and older will comprise over 
20% of the population by the year 2030.  By mid-century it is expected that there will be 
an estimated 88.5 million people age 65 and older. Those who are 65 years and above are 
the fastest growing population group in United States with expectations to increase by 
53.2% by 2020 (U.S. Census Bureau, 2008). As one ages there is an increased risk for 
developing  chronic diseases such as diabetes, cardiovascular disease, arthritis, cancer, 
and COPD (chronic obstructive pulmonary disease) (Fried et al., 1998; Fried et al., 2001; 
Mannino & Buist, 2007; Waltson et al., 2006). These diseases can impact the ability to 
perform activities of daily living, cause physical disabilities, and lead to a loss of 
independence. Disease burden, disability burden, and health care utilization will likely 
intensify as life expectancy increases (Fries, 2003). In 2005, over 132 million people in 
the United States had a chronic condition with one of every four having limitations in 
performing daily activities (Anderson & Horvath, 2004).  
 Frailty is a common term used in geriatric literature to define older adults who are 
at an increased risk for poor clinical outcomes.  It is considered a separate entity from the 
―normal‖ aging process and known to be changeable over time (Gill, Gahbauer, Allore & 
Han, 2006; Hubbard, Fallah, Searle, Mitnitski, & Rockwood, 2009; de Vries, Staal, van 




highly predictive of adverse outcomes such as falls, disabilities, hospitalization, or death 
(Fried et al., 2001) there is no single clinical test or instrument universally used to define 
frailty. 
Based on U.S. studies it is estimated that frailty will affect 7% of those age 65 
years and older, 20% of those age 80 and older, and over 32% in those age 90 and older 
(Fried et al., 2001; Walston et al., 2002).  In one study of older adults (depending on the 
frailty instrument used) the prevalence range of frailty was reported between 33% and 
88%, with the more severe the degree of frailty, the higher the risk of institutionalization 
and death (Fried, et al., 2001; Rockwood, Mitnitski, Song, Steen, & Skoog, 2006).   
There is limited data published on the role of frailty and outcomes in those with 
COPD.  Frailty has been observed in those with COPD especially when shortness of 
breath is present with this population (Park, Richardson, & Larson 2013). A high 
prevalence of frailty in COPD was demonstrated in the Women’s Health and Aging 
Studies (Blaum, Xue, Michelon, Semba, & Fried, 2005). In elderly frail adults with 
COPD a higher mortality was found than in those without COPD (Galizia et al., 2011).  
Still little is known about how frailty is characterized in COPD and the impact of 
frailty on quality of life and health care outcomes in this population. To promote 
improved health in this population, it is important to identify specific indicators that 
contribute to the development of frailty and the impact of frailty on quality of life, health 
care utilization, and death.  This could guide future interventional research and ultimately 
lead to improved outcomes in people with COPD. 
An integral conceptual model of frailty by Gobbens (2010) served as the basis for 




frailty going beyond the physical approach which is the basis for most models of frailty.  
The model was revised for this study to include quality of life outcomes not previously 
explored with Gobben’s model.  
The aims of the study were: 1) to identify demographic characteristics, physical 
frailty indicators, and psychological frailty indicators and their association with health 
related quality of life over time in people with severe COPD, 2) to identify physical and 
psychological frailty indicators and their association with mortality in people with severe 
COPD and 3) to identify demographic characteristics, clinical characteristics, physical 
frailty indicators, and psychological frailty indicators and their association with health 
care utilization over time in people with severe COPD. 
The methodology for analyzing the data included descriptive statistics, correlation, 
regression, and the Kaplan Meier method. The remaining chapters in this dissertation 
provide the background, significance, theoretical framework, conceptual model, 





CHAPTER TWO: BACKGROUND AND SIGNIFICANCE 
Chronic Obstructive Pulmonary Disease 
One of the most significant health problems facing the United States is COPD.  
Studies targeting COPD are important because of the high and increasing prevalence of 
the disease, its severity, and the resulting economic burden (Druss, Antonelli Incalzi et al., 
2002). Currently, COPD affects 15 million people in the United States and is the third 
leading cause of death (exceeded only by heart disease, and cancer), accounting for over 
143,000 deaths in 2011 (Centers for Disease Control [CDC], 2012).  It ranks second in 
the United States for the number of disability-adjusted life years (DALYs) lost due to the 
disease.  The cost of health care for people with COPD in the U.S. is approximately $50 
billion per year which includes both direct and indirect costs (i.e. caretaker expenses and 
lost productivity) and is expected to increase given the increasing prevalence of the 
disease (Guarascio, Ray, Finch, & Self, 2013).  Worldwide, COPD is the fourth leading 
cause of death (CDC, 2012).  
COPD by definition includes both chronic bronchitis and emphysema 
(Andreassen, & Vestbo. 2003). It is a preventable and treatable disease characterized by 
airflow obstruction which is not fully reversible and reflects defects in airway function 
and/or abnormalities in lung parenchyma.  The airflow limitation, usually progressive, is 




or gases. Airflow limitation on spirometry testing and a history of risk factors (with or 
without symptoms) are primarily used to make the diagnosis of COPD.  
COPD is commonly associated with smoking and typically manifests itself in the 
mid-thirties to mid-forties with changes in lung function but generally clinical symptoms 
are not apparent until one reaches their mid-fifties (Pauwels, Buist, Calverly, Jenkins, & 
Hurd, 2001). The clinical symptoms seen in COPD include respiratory symptoms such as 
wheezing, dyspnea, cough, and sputum (Janssens, Pache, & Nocid, 1999; Qaseem et al., 
2007; Stanojevic et al., 2008).  
In any disease state comorbidities can occur, but when they occur in COPD they 
can have a worsening effect on health outcomes. Comorbidities can cause an increase in 
dyspnea and further decline one’s quality of life (Antonelli Incalzi et al., 1997; Barnes & 
Celli, 2009; Celli, 2010). Comorbidities may include: cardiovascular disease, metabolic 
syndrome, osteoporosis, anxiety, depression, lung cancer, diabetes mellitus, pulmonary 
hypertension, obstructive sleep apnea, frailty, skeletal muscle wasting, and skeletal 
muscle dysfunction (Barnes & Celli 2009; Barr et al., 2009; Chatila, Thomashow, Minai, 
Criner, & Make, 2008; Di Marco et al., 2006; Fabbri, Luppi, Beghé, & Rabe, 2008; 
Holguin, Folch, Redd, & Mannino, 2005; Mannino, Thorn, Swensen, & Holguin, 2008).  
The presence of comorbidities, in particular, diabetes, hypertension, cardiovascular 
disease, and cancer increase the risk of death in COPD as well as significantly increase 
health care costs (Foster, Miller, Martin, Caloyeras, Russell, & Menzin, 2006; Galizia et 
al., 2011; Mannino, Thorn, Swensen, & Holgui, 2008). 
Persons with COPD are at risk for a decreased health-related quality of life 




Christopher, 2012).  HRQoL should be measured in this population to have an increased 
understanding of the disease burden.  When a person has more than one comorbidity a 
further decline in HRQoL may occur especially in older people (Parekh, Goodman, 
Gordon, & Koh, 2011).  The relationship between COPD, comorbidities and HRQoL is 
likely to be complex but certainly decreasing comorbidities could assist in improving 
HRQoL (Blinderman, Homel, Billings, Tennstedt, & Portenoy, 2009). 
Health care utilization is increased in people with COPD as it is associated with a 
higher risk of hospitalization and use of an emergency department (Fan, Ramsey, Make, 
& Martinez, 2007; Holguin, Folch, Redd, & Mannino, 2005). Despite the significant 
morbidity and mortality associated with the disease it should be noted that prevalence, 
morbidity, and mortality remain vastly underestimated worldwide. The reasons for this 
include: lack of data from underdeveloped countries, the diagnosis being made when the 
disease is in an advanced state, not making the correct diagnosis, and the failure of COPD 
to be listed as the underlying cause of death on a death certificate.  When COPD is 
considered a contributing cause of death on a death certificate instead of the actual cause 
of death, the mortality rates are underestimated.  
Frailty 
Frailty affects over six million people in the United States (Balducci & Stanta, 
2000). It is recognized as a major public health problem associated with adverse health 
outcomes, disabilities, institutionalization, dependency, and mortality but there is no 
agreement on the definition or measurement methodology (Bandeen-Roche et al., 2006; 




Williamson, & Anderson, 2004; Lee, Buth, Martin, Yip, & Hirsch, 2010; Rockwood, 
Mitnitski, Song, Steen, & Skoog, 2006).   
Frailty in the elderly is intuitively recognized by most geriatricians though it lacks 
a clear operational definition. It is commonly identified relative to physical loss.  The 
American and Italian Geriatricians define physical frailty as impairments in domains that 
include mobility, balance, motor processing, cognition, nutrition (weight change), muscle 
strength, endurance (reflective of exhaustion and fatigue feelings), and physical activity 
(Walston et al., 2006). Others define frailty when a person has increased vulnerabilities to 
stressors and a diminished physiologic reserve capacity, or when a disability puts a 
person at a greater risk of having an adverse outcome (Fried et al., 2001; Morley, Kim, 
Haren, Kevorkian, & Banks, 2005; Morley, Perry, & Miller, 2002; Rockwood, Fox, 
Stolee, Robertson, & Beattie, 1994; Rockwood, 2005; Walston et al., 2006). Each frailty 
definition has its own individual set of components.  Commonly, physical indicators 
serve as the basis for each definition (Fried, et al., 2001; Strawbridge, Sherma, Balfour, 
Higby, & Kaplan, 1998; Studenski, et al., 2004; Winograd, Gerety, Chung, Goldstein, 
Dominquez, & Vallone, 1991). 
Frailty can occur in the absence of a chronic illness.  Data from the 
Cardiovascular Health Study demonstrates that one-quarter of older patients without 
comorbidities exhibit symptoms of frailty but it is also well documented that  some 
chronic illnesses can contribute to frailty (Blaum, Xue, Michelon, Semba, & Fried, 2005; 
Buchner, Beresford, Larson, LaCroix, & Wagner, 1992; Fried at al., 2001; Klein, Klein, 
Knudston, & Lee, 2005; Morley, Haren, Rolland, & Kim, 2006; Newman, et al., 2001; 




diabetes mellitus have been associated with frailty (Klein, Klein, Knudston, & Lee, 2005; 
Morley, Haren, Rolland, & Kim, 2006; Newman, et al., 2001; Reid, Williams, & Gill, 
2005). Persons with chronic obstructive lung disease, depression, anemia, osteoarthritis, 
chronic kidney disease, obesity, low body mass index, and a history of myocardial 
infarction have a higher risk of frailty (Barzilay et al., 2007; Blaum, Xue, Michelon, 
Semba, & Fried, 2005; Buchner, Beresford, Larson, LaCroix, & Wagner, 1992; Fried at 
al., 2001; Wilhelm-Leen, Hall, Tamura, & Chertow, 2009).   
Several studies suggest  lower education levels, lower incomes, African-American 
race, and females have an increased risk of frailty and that frailty increases as age 
increases (Blaum, Xue, Michelson, Semba, & Fried, 2005; Boyd, Xue, Simpson, 
Guralnik, & Fried, 2005; Cigolle, Ofstedal, Tian, & Blaum, 2009; Cohen, Harris, & 
Pieper, 2003; Fried et al., 2001; Gobbens, van Assesn Luijkx, Wijnen-Sponselle, & 
Schols, 2010; Kiely, Cupples, & Lipsitz, 2009;  Mitnitski, Mogilner, MacKnight, & 
Rockwood, 2002; Newman et al., 2001; Ostir, Ottenbacher, & Markides, 2004, Puts, Lips, 
& Deeg., 2005; Rockwood et al., 2004; Romero-Ortuno, Walsh, Lawlor, & Kenny, 2010; 
Walston et al., 2002). In contrast, one group did not find a higher prevalence of frailty in 
older women compared to older men (Strawbridge, Shema, Balfour, Higby, & Kaplan, 
1998). There are two possible reasons for this finding. First, the group included cognitive 
function as an indicator of frailty. Since this was a highly predominant finding of older 
men (within their study) it may have increased the number of males considered frail. 
Second, more of the males were married than females therefore the males had the 




not needing support when in fact they were actually receiving it though they did not view 
it this manner.   
Finally, though numerous studies have examined indicators that characterize 
frailty there are few published studies available that examine frailty and its association 
with COPD.  Additionally, there is a gap in the literature regarding health related 
outcomes as a consequence of frailty in COPD (Blaum, Xue, Michelon, Semba, & Fried, 
2005; Galizia et al., 2011). 
Frailty Outcomes. 
In older people, independent of health status or disease state, those identified as 
frail had a higher rate of disability than those who were not frail (Ensrud et al, 2008; 
Fried et al, 2001). Disabilities such as increased falls and impairments in activities of 
daily living are seen more commonly in older people with frailty (Fried et al., 2001; 
Kiely, Cupples, & Lipsitz, 2009). Theoretically if frailty were prevented or decreased 
then falls and impairments may also be decreased (De Lepeleire, Iliffe, Mann, & Degryse, 
2009, Fried et al., 2001).  Frailty has been highly predictive of death in previous studies 
(Fried et al., 2001; Graham, Snih, Berges, Ray, Markides & Ottenbacher 2009). Findings 
suggest that the frailty process may be slowed down by treating the underlying issue that 
causes frailty such as the loss of muscle mass.  The loss of muscle mass is a major cause 
of frailty and disability in older frail people (Roubenoff, 2000). Exercise and 
interventions to improve physical functioning may reverse frailty (Faber, Bosscher, Chin, 
& van Weiringen, 2006).  This is an important observation since the health care 
utilization of elderly is growing and prevention or reduction of frailty in this population 




Of further significance is the belief that frailty is a dynamic state which allows for 
changes in the level of frailty over time (Gill, Gahbauer, Allore & Han, 2006; Hubbard, 
Fallah, Searle, Mitnitski, & Rockwood, 2009; Rockwood, Fox, Stolee, Robertson, & 
Beattie, 1994; Rockwood, Stolee, & McDowell, 1996). The extent to which this occurs, 
how this occurs, and what interventions may alter frailty levels remain unclear. Future 
research may provide a better understanding of how to alter the frailty process in the 
hopes of improving quality of life and decreasing adverse events in older people. 
Surrogate measures of health and well-being such a HRQoL are readily used in 
research as outcomes measures. The relationship between frailty and HRQoL is unique as 
both frailty and HRQoL are widely used concepts without consensus definitions. In a 
small study of community-dwelling older adults those with frailty had a decreased 
HRQoL (Puts, Shekary, Widdershoven, Heldens, Lips, & Deeg, 2007).  In older Mexican 
Americans with frailty there was a significant association (p < 0.001) with lower HRQoL 
scores (Masel, Graham, Reistetter, Markides, & Ottenbacher, 2009). Others have noted 
that some components of the physical indicators of frailty have been associated with a 
decreased HRQoL (Sayer, Syddall, Martin, Dennison, Roberts, & Cooper, 2006). Limited 
data exist in those with both COPD and frailty but one can hypothesize that a decreased 
HRQoL would be observed in this group. 
It is recognized that frailty is associated with a higher risk of hospitalization and 
long –term care (Fried et al., 2004).  It is estimated that the majority of the 1.6 million 
elderly people living in nursing home are frail (Gabrel, 2000).  A higher rate of 




Voegeli, & Roberts 2013; Walsh, Roberts, Nicholls, & Lattimerl, 2008). Overall, older 
frail individuals are at significant risk for increased uses of health care utilization. 
Theoretical Framework 
The Federal Council on Aging in 1978 described a specific group of older 
individuals as ―frail elderly‖. This frail elderly group needed support from individuals or 
agencies to assist with activities of daily living due to a variety of problems (Hogan, 
MacKnight, & Bergman, 2003).  Over the years the term frailty has evolved from a 
dependence on others to a somewhat more refined concept. Numerous definitions, 
models, and indicators for frailty have been noted in the literature.  Aging, malnutrition, 
decreased strength, loss of muscle mass, chronic illnesses, and inflammation are 
indicators that are associated with frailty in various frailty models (Ahmed, Mandel, & 
Fain, 2007; Bortz, 2002; Gobbens, Luijkx, Wijnen-Sponselee, & Schols, 2010; 
Rockwood, Fox, Stolee, Robertson, & Beattie, 1994; Strandberg, & Pitkala, 2007). While 
it is recognized that a comprehensive geriatric assessment should include a frailty 
assessment a universal accepted method for measuring frailty is not available (Fried et al., 
2001; Mitnitski, Graham, Mogilner, & Rockwood, 2002; Strawbridge, Shema, Balfour, 
Higby, & Kaplan, 1998; Wells, Seabrook, Stolee, Boree, & Knoefel, 2003). 
One of the most widely used approaches to define frailty is the ―frailty phenotype‖ 
published by Fried and colleagues (2001). The frailty phenotype defines frailty as ―a 
biologic syndrome of decreased reserve and resistance to stressors, resulting from 
cumulative declines across multiple physiologic systems‖. Using five criteria they 
developed a ―frailty phenotype‖ (Appendix A).  The criteria include: weight loss, 




indicates a non-frail individual. An individual with one or two criteria present is 
considered pre-frail. An individual with more than two criteria present is considered frail. 
Despite being limited to only physical criteria this phenotype has shown high predictive 
value. In the Cardiovascular Health Study  this phenotype independently predicted a 
three-year incidence or progression of disability in mobility, activities of daily living 
(ADL), hospitalization, and death with unadjusted hazard ratios ranging from 1.82-4.46 
(Fried et al., 2001).  When adjusting for the number of health, disease, and social 
characteristics the hazard ratios ranged from 1.29-2.24 in predicting five-year mortality 
(Fried et al., 2001). Using Fried’s frailty phenotype, the Women’s Health and Aging 
Studies found that frailty strongly predicted disability and mortality independent of a 
disease state (Bandeen-Roche et al., 2006).  
Conceptual Model 
This study was guided by the Integral Conceptual Model of Frailty (Gobbens, 
2010) [Figure 1]. The conceptual model defines frailty using indicators from three 
domains: physical, psychological, and social.  It was chosen to provide additional criteria 
that may be part of frailty outside of Fried’s frailty phenotype of physical criteria only. A 





Life Course Determinants. 
This section of the model views demographic indicators such as age, education, 
income, sex, ethnicity, and marital status as determinants which lead to frailty and 
subsequent adverse events.  It also incorporates living environment, lifestyle, life events, 




status, ethnicity, lifestyle, and living environment have all been found to be associated 
with an increased prevalence of frailty (Blaum, Xue, Michelson, Semba, & Fried, 2005; 
Curcio, Henao, & Gomez 2014, Gobbens, van Assesn Luijkx, Wijnen-Sponselle, & 
Schols, 2010; Woo, Chan, Leung, & Wong, 2010). 
Disease. 
Disease is defined as a decline in physiologic reserve that can lead to frailty. 
Diseases can put one at an increased vulnerability to stressors thereby increasing the risk 
of frailty. Osteoarthritis, congestive heart failure, obesity, chronic kidney disease, and a 
low body mass index have been associated with frailty (Blaum, Xue, Michelon, Semba, 
& Fried, 2005, Fried et al., 2001; Klein, Klein, Knudston, & Lee, 2005; Morley, Haren, 
Rolland, & Kim, 2006; Reid, Williams, & Gill, 2005).  
Physical Domain. 
The physical domain includes a decline in the following indicators: nutrition, 
mobility, physical activity, strength, and sensory functions (vision and hearing). These 
measurement indicators have been included in other existing operational definitions of 
frailty (Buchman, Wilson, Bienias & Bennett, 2009; Ferruci, Guralnik, Studenski, Fried, 
Cutler, & Watson, 2004; Fried et al., 2001; Puts, Lips, & Deeg, 2005; Rockwood et al., 
2005; Strawbridge, Shema, Balfour, Higby, & Kaplan, 1998; Winograd, Gerety, Chung, 
Goldstein, Dominquez, & Vallone, 1991).  
Psychological Domain. 
The psychological domain includes the following indicators: cognition, mood 
(depression and anxiety), and coping. Mood and coping are seen less frequently in other 




Alzheimer’s and other forms of dementia) are part of the Canadian Study of Health and 
Aging (CHSA) Frailty Index and mild cognitive impairments have been observed within 
older frail individuals (Boyle, Buchman, Wilson, Leurgans, & Bennett, 2010; Stuck, 
Walthert, Nikolaus, Büla, Hohmann, & Beck, 1999).  Depression and anxiety have been 
demonstrated to play a role in frailty and are considered mood criteria in this model 
within the psychological domain (Puts, Lips, & Deeg, 2005; Rockwood et al., 2005; 
Schuurmans, Steverink, Linderberg, Frieswijk, & Slaets, 2004; Winograd, Gerety, Chung, 
Goldstein, Dominquez, & Vallone, 1991). The last component of the psychological 
domain is coping.  Coping (or a sense of mastery), meaning the extent to which a person 
has the feeling of being in control of their life, has been examined in one prior 
publication as part of a frailty model (Puts, Lips, & Deeg, 2005). Coping was not found 
to be a significant independent predictor in the above publication. 
Social Domain.  
The social domain includes the following measurement indicators: social relations 
and social support. Currently no other conceptual model of frailty includes social 
relations and social support but Stuck and colleagues (1999) identified limited social 
contacts as a predictor of functional decline during aging and others acknowledge the 
need for a social component of frailty (Bergman, Be´land, Karunananthan, Hummel, 
Hogan, & Wolfson, 1997; Markle-Reid & Browne, 2003).   
Adverse outcomes. 
Disability, health care utilization, and death are included in this domain and this 
has been supported by previous research. Fried’s frailty phenotype has been demonstrated 




(Fried et al., 2001). Frailty has shown prognostic value in predicting mortality and 
morbidity in those undergoing cardiac surgery (Afilalo et al., 2014).  In geriatric trauma 
patients frailty is a significant predictor of an unfavorable hospital discharge (Joseph et 
al., 2014). 
Model Revision for Study 
We have revised the Integral Model of Frailty (Figure 2) to include health related 
quality of life outcomes (HRQoL) and add clinical characteristics for this population. 
HRQoL is a multi-faceted component encompassing several dimensions such as: 
functional and symptom status, perception of health, biological/physical factors, and 
overall well-being (Wilson & Cleary, 1995). HRQoL is frequently used to evaluate the 
impact of health care interventions (Bennett et al., 2003; Browning, Hou, Chui, Deer, & 
Murray, 2003). How one perceives HRQoL can impact health care outcomes (Schmier, 
Chan, & Kline-Leidy, 1998).  Previous studies have reported changes in quality of life in 
those with COPD (Mahler, Tomilson, Olmstead, Tosteson, & O’Connor 1995; 
McSweeney, Grant, Heaton, Adams, & Timms, 1982). It was added to this model as there 
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Figure 2. Revised Integral Conceptual Model of Frailty for this study 
The model used for this study contains the three domains: life course determinants, 
frailty indicators, and outcomes. The demographic characteristics, the physical frailty 
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original conceptual model of frailty.  Clinical characteristics used in this study were 
chosen for theoretical reasons. 
Life course determinants. 
The life course determinants of the frailty include age, gender, race, marital status, 
education and income. The clinical characteristics added to this model include: forced 
expiratory volume 1 second (FEV1), carbon monoxide diffusion capacity (DLCO), total 
lung capacity (TLC), residual volume (RV), partial pressure of oxygen in arterial blood 
(PaO2), and smoking history.  These were chosen to provide a measure of COPD disease 
severity. 
Frailty Indicators. 
In this study, frailty indicators were used from two domains (physical and 
psychological). The social domain was not included because data were not available in 
this data set.   
Physical frailty indicators. 
The physical frailty indicators used include: nutrition, endurance, balance, 
mobility, and sensory function (vision and hearing). These measurement indicators have 
been noted in other existing operational definitions of frailty (Buchman, Wilson, Bienias 
& Bennett, 2009; Ferruci, Guralnik, Studenski, Fried, Cutler, & Watson, 2004; Fried et 
al., 2001; Puts, Lips, & Deeg, 2005; Rockwood et al., 2005; Strawbridge, Shema, Balfour, 







Psychological frailty indicators. 
The psychological frailty indicators used include: cognition, depression, anxiety, 
and coping. Cognition, depression, and anxiety have all been previous used in other  
definitions of frailty (Puts, Lips, & Deeg, 2005; Rockwood et al., 2005; Schuurmans, 
Steverink, Linderberg, Frieswijk, & Slaets, 2004; Winograd, Gerety, Chung, Goldstein, 
Dominquez, & Vallone, 1991).  Though coping was not found to be a significant 
independent predictor in a previous publication, for the purpose of this study, it was 
retained in the model because people with frailty are at risk of adverse outcomes and 
psychological resources may influence how people cope with their physical problems.    
Outcomes. 
The outcomes include HRQoL, death, and health care utilization. The evidence to 
support these outcomes was presented earlier. 
Study Purpose 
 The purpose of this study was two-fold. First, guided by a revision of Gobben’s 
Integral Conceptual Model of Frailty the intent was to identify the association of physical 
and psychological indicators of frailty and their impact on HRQoL and death in those 
with severe COPD. Second:  to identify the association of demographic characteristics, 
clinical characteristics, physical frailty indicators, and psychological frailty indicators 
with frequency of health care utilization in people with severe COPD over time.  Frailty 
is considered a dynamic concept and the revised model allows for changes over time in 
this population (Fried et al., 2001; Gill, Gahbauer, Han, & Allore, 2006; Hubbard, Lang, 
Llewellyn, & Rockwood, 2010; Rockwood, Fox, Stolee, Robertson, & Beattie, 1994; 




Specific Aims and Hypotheses 
The specific aims for this study were: 
Specific Aim 1: To identify demographic characteristics, physical frailty indicators, and 
psychological frailty indicators and their association with HRQoL over time in people 
with severe COPD using the revised model of Gobben’s Integral Conceptual Model of 
Frailty. 
Hypothesis 1.1: The presence of physical and psychological indicators of frailty in 
people with severe COPD will be associated with a decreased HRQoL. 
Specific Aim 2: To identify physical and psychological frailty indicators and their 
association with mortality in people with severe COPD using the revised model of 
Gobben’s Integral Conceptual Model of Frailty.   
Hypothesis 2.1: The presence of physical and psychological indicators of frailty in 
people with severe COPD will be associated with increased mortality.  
Specific Aim 3: To identify demographic characteristics, clinical characteristics, physical 
frailty indicators, and psychological frailty indicators and their association with health 
care utilization over time in people with severe COPD using the revised model of 
Gobben’s Integral Conceptual Model of Frailty. 
Hypothesis 3.1: The presence of certain demographic and clinical characteristics 
in people with severe COPD will be associated with increased health care utilization.  
Hypothesis 3.2: The presence of physical and psychological indicators of frailty in 
people with severe COPD will be associated with increased health care utilization.  





CHAPTER THREE: METHODS 
Research Design 
The sample for this secondary data analysis came from the National Emphysema  
Treatment Trial (NETT).  The NETT was a national study evaluating medical 
management versus lung volume reduction surgery in combination with medical 
management in severe COPD patients. This study was funded by the National Heart, 
Lung, and Blood Institute and the Health Care Financing Administration.  This 
multicenter center trial utilized 17 centers across the United States.  The study was an 
unmasked, randomized trial with prospective accrual of patients with an equal allocation 
for randomization to either medical management or medical management with lung 
volume reduction surgery.   The primary outcome measures were survival and maximum 
exercise capacity.  Secondary measures collected included: quality of life, pulmonary 
function and gas exchange, radiologic studies (chest radiographs, high resolution chest 
CT scans, and nuclear perfusion scans), oxygen requirements, 6 minute hall walk test, 
cardiovascular measures (electrocardiogram, echocardiogram, and heart catheterization 
[if indicated], attention and psychomotor function, and cost effectiveness. An important 
goal of the trail was to identify selection criteria for lung volume reduction surgery.  
Study screening began in 1997 with the first randomization in 1998.  Study duration was 




expected to be of a minority background and 30% expected to be women. All patients 
completed 6 – 10 weeks of pulmonary rehabilitation prior to randomization. Data 
collection occurred at baseline, randomization, 6 months post randomization, 12 months 
post randomization, 24 months post randomization, 36 months post randomization, 48 
months post randomization, and 60 months post randomization (Fishman et al., 2003).  
The study flow chart for the number of patients assigned to each treatment can be seen in 
Figure 3. 
 
Figure 3. Study Flow Chart 
 The final sample for this study was the 610 subjects assigned to medical therapy. 
The surgical arm (n=608) was not included in this study as undergoing a surgical 
procedure has risks and varied outcomes complicating the interpretation of outcomes of 
this study. 
As noted earlier there is no universally accepted method to measure frailty. To 













match those in the Integral Conceptual Model of Frailty.  All life course determinants (ex: 
living environment, lifestyle, and life events) from the original model were not available 
in this data set. The physical and psychological frailty indicators in the revised model 
closely correspond to indicators in the original conceptual model. We did not calculate a 
frailty score but evaluated physical frailty indicators and psychosocial frailty indicators 
and their impact on outcomes in those with severe COPD. The time points for outcomes 
include a baseline measurement, 6 months post randomization, 12 months post 
randomization, 24 months post randomization, and 36 months post randomization. Table 
1 provides an overview of the physical frailty indicators, the psychological frailty 
indicators, and the time points each were measured. 
 
Table 1. 
 Physical Frailty Indicators, Psychological Frailty Indicators, and Time Points Measured 
Indicator       Baseline         6 months         12 months         24 months 36 months 
          post          post             post  post 
          randomization  randomization  randomization  randomization  
________________________________________________________________________ 
 
Nutrition X X X X X 
Endurance X X X X X 
Balance X X X X X 
Mobility X X X X X 
Vision X X X X X 
Hearing X X X X X 
Cognition A X * X X X 
Cognition B X X X X X 
Depression X ** ** ** ** 
Anxiety X ** ** ** ** 
Coping X X X X X 
*Not completed at this time point 








Table 2 lists the demographic characteristics that were used to measure the life 
course determinants from the original model.  The demographic characteristics chosen for 
this study are the same characteristics from the life determinant section of the conceptual 
model. Demographics are widely used in research as they provide essential information 
about the population being studied. The table below provides information on how the 
demographic characteristics were measured in the original study and how they were 





Table 2.  
Demographic Characteristics Table 
Clinical 
Characteristics 
Original Measure Coding 
Age  Actual age in years at 
time of enrollment 
 Number 
Sex  Male  
 Female 
 Male  
 Female  
Race  White (not Hispanic) 
 African American (not 
Hispanic) 
 Hispanic 
 Asian or Pacific Islander 
 American Indian or 
Alaskan Native 
 Other 
 White (Caucasian)  
 Non-white (includes 
all other categories) 
Marital status  Single, never married 
 Separated 
 Divorced or annulled 
 Widowed 
 Married 
 Married  
 Not married 
(includes all other 
categories) 
Education  Did not complete high 
school 
 Completed high school 
 Some college or post high 
school education or 
training 
 Bachelor’s degree or 
higher 
 Did not complete 
high school  
 Completed high 
school 
 Some college or 
post high school 
education or 
training/Bachelor’s 
degree or higher  
Annual Income   Less than $15,000 
 $15,000-$29,999 
 $30,000-$49,999 
 $50,000 or more 
 Less than $15,000 
 $15,000-$29,999 
 $30,000-$49,999 
 $50,000 or more 
 
Demographic characteristics   
Age: In the original data set age ranged from 0-99.  People under age 52 were coded as 0 
and those over 79 were coded as 99.  We recoded age so those previously coded as 0 




there are no people in the study at age 0 and it is unlikely that a person 99 would be in the 
original study. 
Sex: Gender was coded as male or female. 
Race: Race was coded for this study as White (Caucasian) or Non-white (includes all 
other categories).  
Marital status:  Marital status was coded as married or not married (all other categories). 
Education: Education was coded into three categories; 1) did not complete high school, 
2) completed high school, or 3)some college or post high school education or 
training/Bachelor’s degree or higher. 
Income: Income was coded into four categories; 1) less than $15,000, 2) $15,000-
$29,999, 3) $30,000-$49,999, and 4) $50,000 or more. 
Clinical Characteristics 
Pulmonary function tests, arterial blood gases, and smoking history were used to 
reflect disease specific clinical characteristics, the second half of the life course 
determinants. A description of the clinical characteristics and how they were measured in 
the original study is found in Table 3. The clinical characteristics were not part of the 
original conceptual model of frailty though they do theoretically relate to the disease 
section of the model and can provide information on disease severity with this population 
for this study. Pulmonary function testing (FEV1,) is used to measure lung function 
thereby providing a stage of disease severity.  TLC and RV are characteristically 
increased in COPD and as such they provide information about the degree of 
hyperinflation of the lungs. DLCO provides information on how adequate the oxygen 




This again provides us with information regarding disease severity. PaO2 is a 
measurement of the oxygen in arterial blood. This is frequently decreased in people with 
COPD providing information on disease severity. Smoking history was used as a clinical 
characteristic as it provides information on years of smoking relative to the disease 
severity.  Most people with COPD have smoked in excess of 20 pack years. 
Table 3.  
Clinical Characteristics Table 
 Clinical Characteristics  Original Measure 
Forced expiratory volume 
1 second (FEV1), % 
predicted 
 Spirometry (liters) 
Diffusion capacity 
(DLCO), % predicted 
 Single breath diffusion test 
(ml/min/mmHg) 
Total lung capacity 
(TLC), % predicted 
 Plethysmography (liters) 
Residual Volume (RV), % 
predicted  
 Plethysmography (liters) 
Partial pressure of oxygen 
in arterial blood (PaO2) 
 Measured from arterial blood  
 
Smoking history (pack 
years) 
 Self-report of cigarette pack  per day * 
years smoked (pack years) 
 
Clinical characteristics 
In the original data set predicted values for the pulmonary function testing were 
calculated using the predicted equations of Crapo and Morris (Crapo & Morris, 1981; 
Crapo, Morris, & Gardner 1981: Crapo, Morris, Clayton, & Nixon, 1982).  Testing 
performed met American Thoracic Society (ATS) criteria. 
Forced expiratory volume 1 second (FEV1):  FEV1 was obtained by spirometry testing 
with the individual in a sitting position. The actual percentage of predicted was 




bronchodilator percent predicted was used as a continuous indicator and reflects the 
degree of airflow obstruction. 
Diffusion capacity (DLCO): DLCO was obtained with the individual in a sitting 
position by using the actual measured post-bronchodilator DLCO (ml/min/mmHg)/the 
individual’s predicted DLCO (ml/min/mmHg). The post-bronchodilator percent predicted 
was used as a continuous indicator and reflects the extent to which oxygen passes from 
the lungs to the blood. 
Total lung capacity (TLC):  The TLC was obtained by body plethysmography with the 
individual in a sitting position.  The actual percentage of predicted was determined by the 
post-bronchodilator TLC (liters)/ the individual’s predicted TLC (liters). The post-
bronchodilator percent predicted was used as a continuous indicator and it reflects the 
amount of air in the lung contained in the lung at the end of a maximal inhalation. 
Residual Volume (RV): The RV was obtained by body plethysmography with the 
individual in a sitting position.  The actual percentage of predicted was determined by the 
post-bronchodilator RV (calculated by subtracting slow vital capacity [SVC in liters] 
from the TCL [liters]/ the individual’s predicted RV. The post-bronchodilator percent 
predicted was used as a continuous indicator and it reflects the volume of air remaining in 
the lung after a maximal exhalation. 
Partial pressure of oxygen in arterial blood (PaO2): PaO2 was measured with the 
individual rested and in a sitting position on room air.  A radial arterial blood gas was 
drawn and  analyzed. PaO2 was measured in mmHg. The actual measured value in mmHg 




Smoking history: Smoking history was calculated by the number of cigarette packs 
smoked per day times the number of years smoked.  The calculated value was used as a 
continuous indicator. 
Frailty Indicators 
Table 4 lists the physical frailty indicators which were used to measure physical 
frailty as part of the original physical frailty domain in the conceptual model. A 
description of the physical frailty indicators, how they were measured in the original 
study, and how they were coded for this study is provided. The physical frailty indicators 
listed below with the exception of balance were all part of the initial integral conceptual 
model of frailty.  Balance was added to the model as it has been supported by others as a 
predictor of frailty (Dayhoff, Suhrheinrich, Wigglesworth, Topp, & Moore, 1998; Gill, 






 Physical Frailty Indicators   
Physical Frailty  
Indicators 
Original Measure Available responses 
in original data set 
Coded 













 Number  
Balance Over the last 3 days 
did you have: 
 
Difficulty with your 
balance, standing, or 
walking? 
 No days 
 Yesterday 
 2 days ago 
 3 days ago 
A response of ―no 
days‖ was considered 
as having no 
difficulties with 
balance.  All other 
responses were 
considered as having 
difficulties with 
balance. 
Mobility Over the last 3 days 
did you : 
Avoid walking, have 
trouble walking, or 
walk more slowly 
than other people 
your age? 
 No days 
 Yesterday 
 2 days ago 
 3 days ago 
A response of ―no 
days‖ was considered 
as having no 
difficulties with 
mobility.  All other 
responses were 
considered as having 
difficulties with 
mobility.        
Sensory function 
(vision) 
Do you have 
blindness or severely 
impaired vision in 
both eyes? 
 
Do you have 
blindness or severely 









A response of ―yes‖ to 
any one of these 
questions was 
considered as having 
difficulties with vision.  
Sensory function 
(hearing) 
Do you have any 




A response of ―yes‖ 
this question was 














].  The calculated value was used as a continuous indicator. BMI is easily 
measured and has been used to predict outcomes in COPD (Celli, 2010). 
Endurance.  Endurance was measured as the peak watts performed on a cardio-
pulmonary exercise test.  Peak watts have been used as a valid measurement for 
outcomes in several studies with COPD people (Arnardottir, Boman, Larsson, 
Hedenstrom, & Emtner, 2007: Fishman, et al., 2003; Martinez, et al., 2006). Cardio-
pulmonary exercise testing was used to evaluate exercise capacity.  Improvements in 
endurance time during cycling have been noted in people with severe airflow limitation 
after a weightlifting training program (Simpson, Killian, McCartney, Stubbing, & Jones, 
1992). Endurance time has also been closely associated with ventilatory stress (i.e., 
dyspnea) in COPD (Neder, Jones, Nery, & Whipp, 2000). Supplemental oxygen (FiO
2
= 
0.3) was used during the exercise test. A 5 minute resting phase was completed while on 
the cycle and patients were breathing through the circuit.  Following the resting phase 3 
minutes of unloaded pedaling at a cadence between 40 – 70 rpm was completed. Ramp 
rate (5 watts/minutes or 10 watts/minute) for the exercise portion was determined by post 
bronchodilator maximum voluntary ventilation (BDMVV).  If BDMVV ≤ 40.0, ramp rate 
=5 watts/minute; if BDMVV > 40.0, ramp rate =10 watts/minute. Patients began the 
exercise portion, pedaling to achieve 40 rpm or higher. The test ended when cadence 
dropped below 40 rpm and did not return, when the patient requested to end, or when a 
staff member terminated the test for safety. If the patient completed the 5 minute rest 




maximum work was considered to be 0 watts.  The actual peak watts achieved on the 
exercise test was used as a continuous indicator and reflects exercise capacity.  
Balance. Balance was measured by self-report from one question from the Quality of 
Well-being Scale (QWB). There is no available published data to support the use of this 
single question measure as an indicator for balance although overall the QWB was 
initially designed as a general outcome measurement tool and has high correlation (r = 
0.54, p < 0.001) with FEV1 when studied in COPD patients (Kaplan, Atkins, & Timms, 
1984). It is unlikely the balance response would be much different over time (such as if 
the question reflected a longer period of time) without an abrupt change in one’s medical 
condition (Kaplan, Atkins, & Timms, 1984).  The question was ―Over the last 3 days did 
you have: difficulty with your balance, standing, or walking?‖ The response choices were: 
no days, yesterday, 2 days ago, or 3 days ago.   If the answer was yesterday, 2 days ago, 
or 3 days ago it was considered as having difficulties with balance. 
Mobility. Mobility was measured by self-report with one question from the QWB: ―Over 
the last 3 days did you avoid walking, have trouble walking, or walk more slowly than 
people your age?‖ The response choices were: no days, yesterday, 2 days ago, or 3 days 
ago.  If the answer was yesterday, 2 days ago, or 3 days ago it was considered as having 
difficulties with mobility. There is no available published data to support the use of this 
single question measure as an indicator for mobility though problems with mobility are 
commonly seen in the elderly, especially in the frail and elderly population (van Iersela, 
Munnekeb, Esselink, Benraad, & Olde-Rikkert, 2008).  
Sensory function (vision). Vision was measured by self-report with two questions from 




―Do you have blindness or severely impaired vision in one eye?’  A ―yes‖ answer to 
either of the two questions was considered as having difficulties with vision. There is no 
available published data to support the use of this single question measure as an indicator 
for vision. It is a self-reported indicator lacking reliability or validity data.  
Sensory function (hearing). Hearing was measured with one question from the QWB: 
―Do you have any hearing loss or deafness?‖  A ―yes‖ answer to this question was 
considered as having difficulties with hearing. There is no available published data to 
support the use of this single question measure as an indicator for hearing. It is a self-
reported indicator lacking reliability or validity data.  
Table 5 lists the psychological frailty indicators which were used to measure 
psychological frailty as part of the original psychological frailty domain in the conceptual 
model A description of the indicators used to determine psychological frailty, how they 





Table 5.  
Psychological Frailty Indicators 
Psychological 
Frailty Indicators
          
Original Measure Available responses 
in original data set 
Coded 











 Raw score 










 Raw score 









 Raw score 
  
 
Coping Which days (if any) 
over the past 3, not 
including today, you 
have had:  
―Feelings that you 
had little or no 
control over events 
in your life?‖   
 No days 
 Yesterday 
 2 days ago 
 3 days ago 









with coping.  
 
Psychological frailty 
Cognition. Cognition was measured using Trail Making Part A and B (Appendix B) 




attention, concentration and psychomotor functioning (Reitan, 1958). The Trail Making 
Test is a standard component of most neuropsychological screening examinations and 
one of the most widely used tests administered for neuropsychological screening. 
Validity of this test for assessing cognition has been demonstrated in other studies 
(Arbuthnott & Frank 2000; Reitan 1958) Part A requires perceptual motor speed. Part B 
is more challenging requiring perceptual motor speed and the ability to shift back and 
forth between numbers and letters thus the ability for cognitive flexibility is assessed 
(Arbuthnott & Frank, 2000; Lezak, 1983). Part B was also measured and considered for 
inclusion in the analysis though due to the presence of multicollinearity only Part A was 
used. The score is obtained as the number of seconds needed to complete each part. The 
raw score was used as a continuous indicator and reflects cognitive function. 
Mood. Mood was measured for depressive symptoms and anxiety using two self-report 
instruments: the Beck Depression Inventory (BDI) (Appendix C) (Beck, Steer & Brown, 
1996) and the State Trait Anxiety Inventory (STAI) (Appendix D) (Spielberger, 1970).   
Mood (Depression) 
The BDI is widely used to detect possible depression in normal populations. It assesses 
twenty one symptoms and attitudes including: mood, pessimism, sense of failure, lack of 
satisfaction, guilt feelings, sense of punishment, self-dislike, self-accusation, suicidal 
wishes, crying, irritability, social withdrawal, indecisiveness, distortion of body image, 
work inhibition, sleep disturbance, fatigability,  loss of appetite, weight loss, somatic 
preoccupation, and loss of libido (Beck Brown, Steer, Eidelson, & Riskind, (1987). A 
meta-analysis showed the internal consistency estimate for psychiatric patient yielded a 




estimate for non-psychiatric people is acceptable; Cronbach’s alpha is 0.81. The BDI has 
been demonstrated to be a valid brief screening measure of depression (Reynolds & 
Gould, 1981; Storch, Roberti, & Roth, 2004).  The BDI scores were calculated by 
standard procedures and used as a continuous indicator. 
Mood (Anxiety) 
Anxiety was measured using the State Trait Anxiety Inventory (STAI). The STAI is a 
forty item questionnaire that yields two scores: a score associated with the first 20 items 
and a second score associated with the last 20 items. Respondents are asked to rate 
themselves on each item on the basis of a 4-point Likert scale, ranging from ―almost 
never‖ to ―almost always‖ for trait anxiety The scores are weighted with each section 
having a possible score from 20-80.  It was developed as a tool for assessing anxiety in 
normal (non-psychiatric) adults, but has been used in assessing anxiety in medical and 
surgical patients.  The inventory assesses both state and trait anxiety. State anxiety can be 
defined as a temporary emotional state that results from situational stress.  An individual 
demonstrates feelings of apprehension and tension during this transitory period. Trait 
anxiety represents a predisposition to react with anxiety in stressful situations in 
individuals who are generally relatively stable. The last twenty questions of the STAI 
reflect ―trait anxiety‖ which indicate how an individual describes themselves (i.e., how 
they generally feel). To better assess their overall susceptibility to anxiety and not an 
isolated feeling at the moment only the trait anxiety score was included.. The STAI has 
been used in over 3000 studies and has demonstrated internal consistency with a 




validity in previous studies (Marteau & Bekker 1992; The trait anxiety score was used as 
a continuous indicator. 
Coping. Coping was measured by self-report with one question regarding feelings, 
thoughts, and behaviors from the QWB questionnaire. As the model supports the notion 
of an individual’s ability to have control over events in their lives the following question 
was used: ―Which days (if any) over the past 3, not including today, you have had‖: 
―Feelings that you had little or no control over events in your life?‖  The response choices 
were no days, yesterday, 2 days ago, or 3 days ago.    If the answer was yesterday, 2 days 
ago, or 3 days ago it was considered as having difficulties with coping. There is no 
available published data to support the use of this single question measure as an indicator 
for coping although coping styles and coping resources have been associated with 
HRQoL outcomes in people with COPD (Hesselink et al., 2004).  
Outcomes 
Table 6 lists the study outcomes for this study. The outcome variables with the 
exception of HRQoL were part of the original conceptual model of frailty outcome 
section.  HRQoL was added to this model since research has consistently demonstrated 
COPD impairs HRQoL (McSweeney, Grant, Heaton, Adams, & Timms 1982; Stahl, 
Lindberg, Jansson, Ronmark, Svensson, Anderson…Lundback, 2005). A description of 
the outcomes and how they were measured in the original study is provided. 
Outcomes 
 The outcomes for the model included HRQOL, health care utilization, and death. 
Health related quality of life. HRQoL was measured by self-report with the St. 




administered questionnaire provides an overall score which has been validated in 
numerous studies to measure impact on overall health, daily life, and perceived well-
being in people with obstructive airway disease. The original SGRQ demonstrated a 
Cronbach’s alpha of 0.91 for reliability.  When translated to American English the 
internal reliability (Cronbach’s α) was 0.71 (Barr, Schumacher, Freeman, LeMoine, 
Bakst, & Jones, 2000).  The intraclass correlations for test-retest reproducibility for the 
SGRQ range from 0.795 to 0.900 (Jones, Quirk, Baveystock, & Littlejohns, 1992).   The 
SGRQ has demonstrated validity in previous studies in COPD (Jones, Quirk, Baveystock, 
& Littlejohns, 1992; Rutten-van Molken, Roos, & Van Noord, 1999).  
There are 2 parts in this questionnaire which include: symptoms (frequency and 
severity) and activities. Part 1 (symptoms) asks about the frequency of symptoms with a 
1, 3, or 12 month recall. There are several scales for the symptom section with response 
choices from four to five possibilities. Part 2 (activities) asks about activities that are 
limited by breathlessness, social functioning, and psychological disturbances at the 
current time.  The scales for the activity section are all dichotomous (true/false) with the 
exception of the last question which is a 4-point Likert scale. A score is calculated for 
each section as well as an overall score.  Each item within the questionnaire has an 
empirical overall derived weight with final scores ranging from zero to one hundred 
where zero indicates best health and one hundred indicates worst health. In males and 
females (ages 60-69) with no lung disease the average mean score is 11.6 (Ferrer et al., 
1997). In moderate to severe COPD the average scores ranged from 48.3 to 50.5 (Rutten 
van Molken, Roos, & van Noord, 1999).  The continuous score of the SGRQ was used as 




Health care utilization. Health care utilization was measured by self-report with 
multiple questions relating to the type of health care utilized. The information about the 
timing of when health care utilized was prefaced by: ―Health care utilization since the last 
regularly scheduled visit or in the past 3 months, whichever interval is shorter‖. The 
following questions were used:  
―How many nights since that date have you stayed overnight in a hospital or other 
acute care facility?‖ 
―How many nights since that date have you stayed overnight in a rehabilitation 
hospital, nursing home, or other non-acute care facility?‖ 
―How many times since that date have you been seen at any emergency room 
(department), triage area, or urgent care facility?‖ 
―How many times since that date have you visited a physician, physician’s 
assistant, or a nurse in their office or have you visited an outpatient clinic for any 
reason?‖ 
―How many times since that date has a health care professional/provider (e.g. 
home health agency nurse, physical therapist, occupational therapist) visited your 
residence?‖ 
―How many times since that date has a health care service worker (aide/attendant) 
or a health equipment technician come to your residence for health reasons or to 
adjust, service, or care for some item of health equipment used by you?‖ 
The health care utilization questions ask about overnight stays, visits to health 
care providers and visits to homes. For ease of interpretation of the results we recoded 




to a facility  (―How many nights since that date have you stayed overnight in a hospital or 
other acute care facility?‖ and ―How many nights since that date have you stayed 
overnight in a rehabilitation hospital, nursing home, or other non-acute care facility?‖) 
were recoded as hospital/non-hospital overnight stays. Group 2: The questions that 
involved a visit to a health care provider (―How many times since that date have you been 
seen at any emergency room [department], triage area, or urgent care facility?‖ and ―How 
many times since that date have you visited a physician, physician’s assistant, or a nurse 
in their office or have you visited an outpatient clinic for any reason?‖) were recoded to 
provider visits. Group 3: The questions that involved health care providers going to the 
home (―How many times since that date has a health care professional/provider [e.g. 
Home health agency nurse, physical therapist, occupational therapist] visited your 
residence?‖ and ―How many times since that date has a health care service worker 
[aide/attendant] or a health equipment technician come to your residence for health 
reasons or to adjust, service, or care for some item of health equipment used by you?‖) 
were recoded to home care visits. 
The responses were used as a continuous indicator. 
Death. All-cause mortality was included in this study for each individual. Death was 
ascertained as of December 2008, by reports from the participating clinical centers and 
review of the Social Security Administration’s Master Death File. Death was coded as 









Outcomes  Original Measure 
Health Related 
Quality of Life 
 St. George’s Respiratory Questionnaire  




Health care utilization since the last regularly scheduled 
visit or in the past 3 months, whichever interval is shorter. 
 
 How many nights since that date have you stayed 
overnight in a hospital or other acute care facility? 
 
 How many nights since that date have you stayed 
overnight in a rehabilitation hospital, nursing home, 
or other non-acute care facility? 
 
 How many times since that date have you been seen 
at any emergency room (department), triage area, or 
urgent care facility? 
 
 How many times since that date have you visited a 
physician, physician’s assistant, or a nurse in their 
office or have you visited an outpatient clinic for 
any reason? 
 
 How many times since that date has a health care 
professional/provider (e.g. Home health agency 
nurse, physical therapist, occupational therapist) 
visited your residence? 
 
 How many times since that date has a health care 
service worker (aide/attendant) or a health 
equipment technician come to your residence for 
health reasons or to adjust, service, or care for some 
item of health equipment used by you? 
 







Protection of Human Subjects 
 This was a secondary data analysis.  All data were de-identified.  Data were 
obtained from the NHLBI BioLINCC (Biologic Specimen and Data Repository 
Information Coordinating Center) after Institutional Review Board (IRB) approval was 
granted from the University of Michigan.  Data were stored on a password protected 
computer accessible only to research team members. 
Analysis 
 Statistical tests were conducted using SPSS (Version 20.0, SPSS Inc. Chicago, 
IL).  Prior to analysis all of the indicators were reviewed for missing values, outliers and 
fit between distributions and the assumptions of multivariate analysis such as: 1) presence 
of a linear relationship between the indicators, 2) homoscedasticity, 3) normal 
distribution of the data, and 4) multicollinearity and singularity (Tabachnick & Fidell, 
2007). For the demographic characteristics, income was not available on one case.  For 
the clinical characteristics smoking history was not available on 3 cases.  In regression 
missing values by default are eliminated.  This was also the case for this study.  The 
missing values were eliminated in the regression models.  The final sample size is 
provided in the tables at each time point for the analysis. 
Linearity and homoscedasticity were evaluated by examination of bivariate 
scatterplots and residual plots. Bivariate scatterplots suggested a linear relationship was 
evident and the rectangular patterns in the residual plots indicated homoscedasticity of 




Having normally distributed variables (indicators) is an underlying assumption of 
many statistical tests (Tabachnick & Fidell, 2007).  To assess the normality of the 
distributions of the continuous indicators, normal probability plots and boxplots were 
utilized. Normal distribution of all continuous indicators was found. 
 Multicollinearity is present when the variables (indicators) are highly correlated, 
whereas singularity exists when the variables are too similar (or redundant) as when two 
or more of the variables are actually measuring the same thing (Tabachnick & Fidell, 
2007).  Multicollinearity was examined using Pearson product moment correlation 
coefficients.  A review of the correlation matrix revealed that there was a strong positive 
correlation (r = .62, n= 608, p < 0.01) between Trail Making Part A and Trail Making 
Part B therefore as noted earlier, only Trail Making Part A was used in the analysis.  The 
two mood indicators, depression (BDI) and anxiety (STAI) were also highly correlated at 
each time point (r = .68, n= 610, p < 0.01). Despite the finding of a high correlation 
between these two indicators, both were retained for analysis since prevalence rates for 
anxiety, depression, or both in COPD vary widely and have been reported to range from 
10% up to as high as 79% with depression seen more frequently in females than males 
(Barnes 2010; Barnes & Celli, 2009; DiMarco et al., 2006).  No other physical frailty 
indicators or psychological frailty indicators were found to be highly correlated.  
Following evaluation of assumptions, descriptive statistics were computed to 
assess the distribution of the demographic and clinical characteristics and all values were 
found to be within the expected range. The means and standard deviations for all the 
indicators were found to be plausible. A summary of demographic and clinical 





Specific aim1  
  A linear hierarchical block regression model was used to examine the association 
of demographic characteristics, physical frailty indicators, and psychological frailty 
indicators with HRQoL. The R
2
 was reported as a measure of the proportion of variance 
in HRQoL explained by the frailty indicators in the multivariate analyses. In the 
regression models the B is the unstandardized coefficient.  This means the coefficient is 
presented in the same scale of the original indicator. In the regression models the β is the 
standardized coefficient.  This means the indicators in the model have been standardized 
by ―z‖ scores to represent change in terms of standard deviation units. Standardized 
relationships say that for a one-standard deviation increment on the predictor indicator, 
the outcome indicator increases (or decreased) by some number of standard deviation 
corresponding to what the β is. The independent indicators were entered into the equation 
at each time point based on the theoretical concepts within the model of their related 
importance to add to the prediction of the HRQoL. The demographic characteristics were 
entered in the first block. The physical frailty indicators were entered in the second block.  
The psychological frailty indicators were entered in the final block. 
Specific aim 2  
The Kaplan-Meier method was used to analyze the physical and psychological 
frailty indicators with death. The Kaplan-Meier survival curve computes the probability 
of surviving a certain length of time while considering time in many small intervals (Goel, 
Khanna, & Kishore, 2010).  Using the Kaplan-Meier assumes three criteria are met: 1) 




the study, 2) we assume the event happens at the time specified, and 3) we assume that 
censored individuals have the same survival probability as those who are still in the study. 
Specific aim 3 
A linear block regression model was used to examine the association of 
demographic characteristics, clinical characteristics, physical frailty indicators, and 
psychological frailty indicators with health care utilization. The independent indicators 
were entered into the equation at each time point based on the theoretical concepts within 
the model. The demographic characteristics were entered in the first block. The clinical 
characteristics were entered in the second block.  The physical frailty indicators were 
entered in the third block. The psychological frailty indicators were entered in the final 
block. 
   




CHAPTER FOUR: RESULTS 
Demographic and Clinical Characteristics 
Demographic characteristics are summarized in Table 7.  Participants had a mean 
age of 66.51 years of age.  The majority were male (64.1%), white (94.3%), and married 
(64.9%).  Only 16.9% of the sample had a bachelor’s degree or higher and 21.1% of the 
sample had not graduated from high school. The majority of the sample had a household 
income ranging from $15,000 to $49,999 (62.7%).   
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Table 7.  
Sample demographic characteristics at baseline (n =610) 
______________________________________________________________ 
Characteristics                 n (%) 
______________________________________________________________ 
Age, yrs. (+SD)     66.51 ± 5.756 
   
Gender       
 
   Male       391 (64.1 %) 
   Female      219 (35.9%) 
Ethnicity 
   Caucasian (white)     575 (94.3%) 
   Non-white      35   (5.7%) 
Marital status 
   Single, never married    18   (3%) 
   Separated      12   (2%) 
   Divorced or annulled    88   (14.4%) 
   Widowed      96   (15.7%) 
   Married      396 (64.9%) 
Education level 
   Did not complete high school   129 (21.1%) 
   Completed high school    169 (27.7%) 
   Some college (post high school or training) 209 (34.3%) 
   Bachelor’s degree or higher    103 (16.9%) 
Economic status (per year income)* 
   < $15,000      112 (18.4%) 
   
48 
 
   $15,000-$29.999     204 (33.4%) 
   $30,000-$49,999     178 (29.2%) 
   $50,000 or more     115 (18.9%) 
    ________________________________________________________ 
*Percentage does not add up to 100% due to 1 missing case 
 
 
The sample was severe in their COPD disease classification (Table 8) with a 
mean post bronchodilator FEV1 of 26.97% (7.11) of predicted value.  Total lung capacity 
and residual volumes were increased in the sample while both mean DLCO and partial 
pressure of oxygen in arterial blood were decreased. The average smoking pack year 
history was 66.43 (32.84) pack years. 
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Table 8.  
 
Sample clinical characteristics at baseline (n =610) 
________________________________________________________________ 
 
Characteristics                 Mean ± SD 
________________________________________________________________ 
 
Forced expiratory volume one second (FEV1) % predicted    26.97 (7.11) 
Diffusion capacity (DLCO) % predicted       28.39 (9.76) 
Total lung capacity (TLC) % predicted     129.23 (14.04) 
Residual volume (RV) % predicted     226.60 (48.19) 
Partial pressure of oxygen in arterial blood (Pa02) mmHg (on room air)   64.55 (10.17) 
Smoking history (pack years)        66.43 (32.83) 
_______________________________________________________________________ 
*DLCO not available on 4 subjects. Smoking history not available on 3 subjects. 
 
Physical and Psychological Frailty Baseline Indicators 
 Approximately half of the sample (49.2%) was of normal weight with an average 
BMI of 24.87 (3.74).  Only 3% of sample were considered underweight (BMI < 18.5) at 
the time of baseline screening.  At the initial baseline screening the majority of the 
sample reported no difficulties with balance (92.3%) though difficulties with mobility 
were reported in 79.5% of the sample.  At the initial baseline screening the majority of 
the sample did not report vision (90.7%) or hearing difficulties (72.3%) though 92.3% 
reported wearing glasses or contacts lenses. The majority of the sample reported no 
problems with cognition (96.4%) or coping (83.6%) at baseline.  Slightly over half of the 
sample reported no depressive symptoms (59.2%) or anxiety issues (57.2%) at baseline. 
The mean for endurance measured by peak watts during a cardio-pulmonary 
exercise bike test was 41.31 (22.06) watts for males and 26.68 (14.89) watts for females. 
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An independent-samples t-test was conducted and a significant difference in scores for 
males and females was found; t (572.58) = 9.60, p = < .001. 
The linear relationships between demographic characteristics and physical and 
psychological frailty indicators at baseline are found in Table 9. There was a positive 
correlation between income and education, r = .320, n = 610, p = < .001; endurance and 
gender, r = .335, n = 610, p = < .001; anxiety and depression, r = .682, n = 610, p = 
< .001; coping and depression (r = .416, n = 610, p = < .001); and coping with anxiety (r 
= .389, n = 610, p = < .001). 
Table 9. 
Correlation matrix for demographic characteristics and physical and psychological 
indicators of frailty. 
 
Note: ** p <0.01, *p <0.05.   
  
  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1. Age 1                
2. Gender .132** 1               
3. Race .054 -.052 1              
4. Marital status .115** .238** .099* 1             
5. Education .093* -.031 .049 -.021 1            
6. Income .171** .110** .085* .426** .320** 1           
7. Nutrition -.088* .071 .068 .020 -.058 -.028 1          
8. Endurance -.023 .335** -.013 .093* .093* .115** .163** 1         
9. Balance -.073 -.097* .008 -.004 -.090* -.074 .004 -.047 1        
10. Mobility -.004 -.025 .059 .021 .018 .026 .008 -.183** .094* 1       
11. Vision .053 -.003 -.004 .003 .018 -.072 -.057 .030 -.004 -.040 1      
12. Hearing .142** .182** .102* .092* .028 .112** .000 .120** .054 -.080 .040 1     
13. Cognition .151** .064 -.084* .001 -.185** -.068 -.084* -.109** -.009 -.017 .117** .028 1    
14. Depression -.155** -.094* -.015 -.042 -.102* -.067 -.001 -.071 .089* .140** .022 -.064 .042 1   
15. Anxiety -.147** -.151** -.037 -.061 -.134** -.125** -.045 -.109** .141** .141** .056 -.032 .113** .682** 1  
16. Coping -.090* -.115** -.056 -.054 -.010 -.038 .007 -.054 .137** .095* .115** -.039 -.068 .416** .389** 1 
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Health-Related Quality of Life outcome 
Hierarchical regression was used to assess the ability of the demographic 
characteristics, physical frailty indicators, and psychological frailty indicators at baseline 
to predict HRQoL. The baseline model summary for HRQoL at baseline is provided 
below.  The model summaries for the remaining time points are in the appendices. Age, 
gender, race, marital status, education, and income were entered at Step 1 (at baseline), 
explaining only 4% of the variance in HRQoL. At Step 2 after entry of the physical 
frailty indicators (nutrition, endurance, balance, mobility, vision, and hearing) the total 
variance explained by the model was 23%, F (12, 571) =13.97, p = < .001. In the final 
model at Step 3 after entry of the psychological frailty indicators (cognition, depression, 
anxiety, and coping) the total variance explained by the model was 36%, F (16, 567) = 
20.31, p = < .001. 
At baseline, in the final model summary both Model 2 and Model 3 overall were 
significant predictors (p = < .001) of HRQoL.  Table 10 shows the R squared (R
2
), F for 
change in R
2
 for the models at baseline. 
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Table 10.  
 












.039   3.94   .001* 
Model 2 
 
.227 23.11  <.001**  
Model 3 .364 30.63  <.001**  
  
**p < .001, *p < .05 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income/ nutrition, 
endurance, balance, mobility, vision, and hearing. 
c. Model 3 includes: age, gender, race, marital status, education, income/ nutrition, 
endurance, balance, mobility, vision, hearing/ cognition, depression, anxiety and coping. 
 
Table 11 shows the coefficients, (B), t-values and p-values for demographic 
characteristics, physical frailty indicators, and psychological frailty indicators as 
predictors of HRQoL for the final model summary at baseline. Age, gender, endurance, 
balance, mobility, coping, and depression were found to be significant (p = < .05) 
individual baseline indicators for predicting quality of life. 
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Table. 11.  
Coefficients (β), t-values, and p-values for Demographic Characteristics and the Frailty 
Indicators as Predictor of Health Related Quality of Life in Final Model at Baseline 
(n=604) 
Indicators         B                      β         t-value        p-value 
(Intercept) 46.078   8.739 .001 
Age  -.100 -.079 -2.216 .027 
Race 1.149 .021 .607 .544 
Income .038 .003 .073 .942 
Marital status 1.970 .073 1.893 .059 
Education -.882 -.055 -1.474 .141 
Gender 3.002 .112 2.957 .003 
Nutrition .079 .023 .673 .501 
Endurance -.118 -.193 -5.138 .001 
Balance 5.541 .106 3.086 .002 
Mobility 7.620 .234 6.658 .001 
Vision -2.141 -.046 -1.328 .185 
Hearing .186 .006 .184 .854 
Coping 3.492 .097 2.555 .011 
Cognition .046 .057 1.600 .110 
Anxiety .065 .053 1.097 .273 
Depression .645 .297 6.084 .001 
 




 At six months post randomization (Appendix Table F1) age, gender, endurance, 
balance, mobility, coping, and depression  remained significant predictors in addition to 
education level (p= <0.05).  The final summary model at 6 months post randomization 
can be found in Appendix Table F2.  The final R
2
 for 6 months post randomization 
was .438. 
At twelve months post randomization (Appendix F3) education became less 
significant as a predictor of HRQoL (p = <.06) though age, gender, endurance, mobility, 
balance, coping and depression remained significant (p = <.05).  The final summary 
model at 12 months post randomization can be found in Appendix Table F4.  The final R
2
 
for 12 months post randomization was .399. 
At twenty four months post randomization (Appendix F5)  age, gender, and 
balance were no longer significant predictors though education once again became a 
significant predictor along with endurance, mobility, coping, and depression (p = <.05). 
The final summary model at 24 months post randomization can be found in Appendix 
Table F6. The final R
2
 for 24 months post randomization was .356 
. At thirty six months post randomization (Appendix Table F7) only mobility and 
coping remained as significant predictors of HRQoL (p = <.001). The final summary 
model at 36 months post randomization can be found in Appendix Table F8. The final R
2
 
for 36 months post randomization was .473. 
Death outcome 
 A K-means cluster analysis was done using the physical and psychological frailty 
indicators to determine high/ low frailty clusters and evaluate survival between the 
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groups.  Cluster 1 (n =185; censored =84) was defined in this study as having a lower 
frailty likelihood. Cluster 1 is characterized by: higher endurance, higher nutrition (i.e., 
higher BMI), lower anxiety difficulties, lower cognition difficulties, and no problems 
with balance, coping, vision or hearing.  Cluster 2 (n = 396; censored =88) was defined in 
this study as having a higher frailty likelihood). Cluster 2 is characterized by: lower 
endurance, lower nutrition (i.e., lower BMI) higher anxiety difficulties, higher cognition 
difficulties, and no balance, coping, vision or hearing difficulties.  A Kaplan-Meier 
survival curve (Figure 4) was done using the two defined clusters to assess the probability 
of survival between those with lower frailty likelihood and those with higher frailty 
likelihood in people with severe COPD.  Figure 4 includes the censored cases. The 
censored cases are those who dropped out of the study or the study ended for them. There 
was a statistically significant difference (p = < .001) between the groups.  50% of Cluster 
1 (low frailty likelihood) survived 2718 (165.13) days.  50% of Cluster 2 (high frailty 
likelihood) survived 1702 days (93.78).  This translates into 7.4 years compared to 4.7 
years median survival time. 
 




Figure 4. Kaplan Meier Curve for Probability of Survival for Cluster 1 and Cluster 2 
(n=581) 
 
Health care utilization outcome 
A linear regression model method was used to assess the ability of the 
demographic and clinical characteristics, physical frailty indicators, and psychological 
frailty indicators to predict health care utilization. Health care utilization was assessed by 
three groups: Group 1) overnight stay to a facility; Group 2)  a visit to a health care 
provider; Group 3) a home visit by a health care. The baseline model summaries for each 
health care utilization group are provided below.  The model summaries for the 
remaining time points are in the appendicies. 
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Overnight stay in a hospital, acute/nonacute care facility, rehabilitation hospital, nursing 
home 
For Group 1:  In the model summary Model 1 (Table 12) demonstrated 
signifcance (p = <.05) at predicting an overnight stay in a hospital, acute care facility, 
rehabilitation hospital, nursing home, or a non acute care facility at baseline.  Education 
and depression were significant individual indicators (p = <.05) predictive of an 
overnight stay in a hospital, acture care facility, rehabilitation hospital, nursing home or a 
non acture care facility in the model (Table 13).  
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Table 12.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of the number of overnight stays in a hospital, acute care facility, 
rehabilitation hospital, nursing home, or non-acute care facility at baseline (n=609) 
Model R
2





     P 
Model 1 
 
.023 2.282   .035 
Model 2 
 
.035 1.213 .298 
Model 3 .042 .617 .717 
Model 4 .052 1.486 .205 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income/, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), and RV % predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD)/ vision, mobility, balance, hearing, nutrition, 
and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO %  predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD)/ vision, mobility, balance, hearing, nutrition, 
endurance/ coping, cognition, anxiety, and depression. 
PBD = post bronchodilator, PY=pack years, RA = room air 
  




Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and the Frailty Indicators as predictors of the number of overnight stays 
in a hospital, acute care facility, rehabilitation hospital, nursing home, or non-acute care 
facility in final model at baseline (n=609) 
Indicators             B                   β        t-value        p-value 
(Intercept) .568   1.293 .197 
Age  <.001 .004 .078 .938 
Race .110 .053 1.240 .216 
Income .006 .011 .229 .819 
Marital status -.012 -.012 -.246 .805 
Education -.070 -.116 -2.488 .013 
Gender -.055 -.055 -.931 .352 
FEV1 (PBD) -.001 -.012 -.189 .850 
TLC (PBD) -.002 -.049 -.668 .505 
RV (PBD) .000 .014 .155 .877 
PaO2 (RA) <.001 -.002 -.039 .969 
DLCO (PBD) 
 
-.003 -.053 -1.026 .305 
Smoking (PY) <.001 .021 .485 .628 
     
Nutrition <.001 .000 -.008 .993 
Endurance -.001 -.052 -.924 .356 
Balance .055 .028 .658 .511 
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Mobility -.007 -.005 -.125 .900 
Vision .106 .060 1.409 .159 
Hearing -.042 -.039 -.900 .368 
Coping -.098 -.072 -1.546 .123 
Cognition -.001 -.019 -.417 .677 
Anxiety -.002 -.043 -.728 .467 
Depression .010 .127 2.115 .035 
PBD = post bronchodilator, PY=pack years, RA = room air 
At six months post randomization (Appendix Table G1) and 12 months post 
randomization (Appendix Table G3) none of the models were significant in predicting an 
overnight stay in a hospital, acute care facility, rehabilitation hospital, nursing home, or 
non acute care facility. There were no individual indicators at 6 months post 
randomization (Appendix Table G2) or 12 months post randomization (Appendix Table 
G4) found to be significant at predicting an overnight stay in a hospital, acute care facility, 
rehabilitation hospital, nursing home, or non acute care facility .  
At twenty four months post randomization in the model summary, Model 3 
(Appendix Table G5) was significant (p = .008) at predicting an overnight stay in a 
hospital, acute care facility, rehabilitation hospital, nursing home, or non acute care,  The 
significant indicators (Appendix G6) were smoking history (p = .050) and balance (p 
= .001).  
  At thirty six months post randomizaton none of the models (Appendix Table G7) 
were significant at predicting an overnight stay in a hospital, acute care facility, 
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rehabilitation hospital, nursing home, or non acute care facility and there were no 
significant indicators (Appendix  G8). 
Visit to an emergency room (triage/urgent care) or health care provide (MD/PA/RN) 
 For Group 2 none of the models (Table 14) were significant at predicting a visit to 
an emergency room or health care provider at baseline. An isolated indicator (Table 15) 
of gender (p = .010) was found to be significant though again overall none of the models 
were significant at predicting a visit to an emergency room or health care provider.   
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Table 14.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of the number of visits to an emergency room (including triage 
and urgent care) or visits to a health care provider (physician, physician’s assistant, 
nurse) at baseline (n=609) 
Model R
2





   P 
Model 1 
 
.009 .858 .526 
Model 2 
 
.017 .767 .596 
Model 3 .025 .780 .586 
Model 4 .029 .568 .686 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), and RV % predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD)/ vision, mobility, balance, hearing, nutrition, 
and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO %  predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD)/ vision, mobility, balance, hearing, nutrition, 
endurance/ coping, cognition, anxiety, and depression. 
PBD = post bronchodilator, PY=pack years, RA = room air 
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Table 15.  
Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of the  number of visits to an 
emergency room (including triage and urgent care) or visits to a health care provider 
(physician, physician’s assistant, nurse) in final model at baseline (n=609) 
Indicators         B                  β       t-value        p-value 
(Intercept) 1.035   2.883 .004 
Age  -.007 -.100 -1.941 .053 
Race .048 .028 .658 .511 
Income .001 .002 .040 .968 
Marital status -.020 -.025 -.512 .609 
Education .008 .016 .336 .737 
Gender .125 .154 2.591 .010 
FEV1 (PBD) .001 .013 .205 .838 
TLC (PBD) .003 .126 1.701 .090 
RV (PBD) -.001 -.150 -1.602 .110 
PaO2 (RA) <.001 .009 .185 .853 
DLCO (PBD) 
 
-.003 -.064 -1.224 .222 
Smoking (PY) <.001 .002 .040 .968 
Nutrition .002 .017 .369 .712 
Endurance -.001 -.059 -1.020 .308 
Balance -.058 -.037 -.853 .394 
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Mobility .014 .014 .312 .755 
Vision .086 .060 1.399 .162 
Hearing .018 .021 .474 .635 
Coping .008 .007 .151 .880 
Cognition <.001 .009 .205 .838 
Anxiety .002 .042 .698 .486 
Depression .002 .025 .405 .686 
PBD = post bronchodilator, PY=pack years, RA = room air 
 At six months post randomization in the model summary (Appendix Table H1) 
Model 3 was significant (p = .003) at predicting a visit to an emergency room or health 
care provider. The significant indicators (Appendix Table H2)  were FEV1(PBD) (p 
= .021) and endurance (p = .001).  
  At twelve months post randomization none of the models (Appendix Table H3) 
were significant at predicting a visit to an emergency room or health care provider though 
income (p = .031) and PaO2 (RA) (p = .039) were significant indicators (Appendix Table 
H4).  
  At twenty months post randomization (Appendix Table H5) and 36 months post 
randomization (Appendix Table H7)  there was no model or indicators (Appendix Table 
H6 and Appendix Table H8)  found to be significant at predicting a visit to an emergency 
room or health care provider.   
   
65 
 
Home care visit 
 For Group 3:  In the model summary Model 2 (Table 16) was significant (p = 
< .001) at predicting a home visit by a health care provider.  The significant indicators 
(Table 17) were PaO2 (RA) (p = <.001) and DLCO (p = .004) at baseline.  
Table 16.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and  Frailty 
Indicators as predictors of the number of home visits by a health care provider (home 
health agency nurse, physical therapist, occupational therapist) or health care service 
worker (aide/attendant, health equipment technician) at baseline (n=609) 
Model R
2





     P 
Model 1 
 
.014   1.402    .211 
Model 2 
 
.160 16.463  <.001 
Model 3 .169   1.074    .377 
Model 4 .172     .493    .741 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), and RV % predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD)/ vision, mobility, balance, hearing, nutrition, 
and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income/ TLC % 
predicted (PBD), DLCO %  predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD)/ vision, mobility, balance, hearing, nutrition, 
endurance/ coping, cognition, anxiety, and depression. 
PBD = post bronchodilator, PY=pack years, RA = room air 
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Table 17.  
Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and the Frailty Indicators as predictors of the number of home visits by 
a health care provider  (home health agency nurse, physical therapist, occupational 
therapist) or health care service worker (aide/attendant, health equipment technician in 
final model at baseline (n=609) 
Indicators          B                β       t-value       p-value 
(Intercept) 3.085   3.382 .001 
Age  -.004 -.022 -.453 .651 
Race .069 .015 .375 .708 
Income -.012 -.011 -.237 .813 
Marital status -.076 -.034 -.761 .447 
Education -.019 -.014 -.326 .745 
Gender -.103 -.046 -.840 .401 
FEV1 (PBD) -.016 -.106 -1.843 .066 
TLC (PBD) .007 .090 1.322 .187 
RV (PBD) -.002 -.088 -1.017 .310 
PaO2 (RA) -.026 -.244 -5.641 <.001 
DLCO (PBD) 
 
-.015 -.140 -2.894 .004 
Smoking (PY) <.001 -.014 -.345 .730 
Nutrition .014 .049 1.143 .253 
Endurance -.005 -.103 -1.937 .053 
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Balance -.043 -.010 -.250 .803 
Mobility -.008 -.003 -.073 .942 
Vision .107 .027 .685 .494 
Hearing .092 .038 .944 .346 
Coping -.046 -.015 -.347 .729 
Cognition .002 .035 .838 .402 
Anxiety .005 .053 .945 .345 
Depression -.008 -.046 -.824 .410 
PBD = post bronchodilator, PY=pack years, RA = room air 
At six months post randomization in the model summary (Appendix Table I1) 
Model 2 was significant (p = < .001) at predicting a home visit by a health care provider.  
The significant indicators (Appendix Table I2) were PaO2 (RA) (p = <.001) and smoking 
history (p = .015).  
At twelve months post randomization in the model summary (Appendix Table I3) 
Model 2 was significant (p = < .001) at predicting a home visit by a health care provider.  
The significant indicators (Appendix Table I4) were TLC (p = .006), PaO2 (RA) (p = 
<.001) and DLCO (p =.006).   
At twenty four months post randomization in the model summary (Appendix 
Table I5) Model 2 was significant (p = < .05) at predicting a home visit by a health care 
provider. The significant indicators (Appendix Table I6) were PaO2 (RA) (p = <.001), 
nutrition (p = .033), and endurance (p = .024).  
  At thirty six months post randomization in the model summary (Appendix Table 
I7) Model 2 was significant (p = < .05) at predicting a home visit by a health care 
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provider. The significant indicators (Appendix Table I8) were gender (p = .035), RV % 
predicted (PBD) (p= .020), PaO2 (RA) (p = <.001) and endurance (p = <.001). 
 




CHAPTER FIVE: DISCUSSON 
This is the first study to examine frailty as a predictor of HRQOL longitudinally 
over time in people with severe COPD.  At baseline the physical indicators of frailty 
accounted for a significant amount of the variance in HRQOL independent of 
demographic and clinical variables.  The psychological indicators accounted for a 
significant amount of the variance in HRQOL independent of the effects of demographic 
characteristics, clinical variables and physical indicators of frailty.  Mobility and coping 
at baseline were important predictors of long term HRQOL.  High frailty predicted 
mortality, but did not predict health care utilization.  Clinical variables of COPD severity 
predicted health care utilization. 
These results highlight the importance of including both physical and 
psychological variables as indicators of frailty, especially when predicting HRQOL. 
Many of the physical and psychological indicators of frailty were significant predictors of 
HRQOL at one or two years, but only mobility and coping were significant predictors of 
HRQOL at three years. Most of the prior work with frailty has been using health care 
utilization and mortality as outcomes and psychological difficulties as a frailty indicator 
is indeed lacking in the literature.   
Mobility is not typically included as an indicator of frailty in most models, but it 
performed well in our revised Gobben’s model, suggesting that it may be useful to retain 
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mobility in future frailty research, especially for people with severe COPD.  The 
importance of mobility could be explained by several factors. First, impairment in 
mobility is frequently seen in people with COPD (Jacome, Marques, Gabriel, & 
Figueiredo, 2013) and mobility is linked to subjective levels of dyspnea, an important 
activity-limiting symptom of COPD (Katajisto et al., 2012). Further research would be 
needed to determine if it was a useful frailty indicator for people in the earlier stages of 
COPD since there is likely less variability in earlier stages of the disease.  Additionally, 
there has not been a lot of work done in early stage COPD because it is largely 
underdiagnosed.   
It is interesting to note that endurance did not predict long term HRQOL, possibly 
because it is readily modified by physical activity.  Endurance declines rapidly with 
inactivity and is sensitive to short term events thus less likely to be a good predictor of 
long term outcomes.  Balance may behave similarly.  In contrast walking is a very basic, 
low-level skill and is less sensitive to smaller changes in activity levels.  As a low level 
skill walking is essential to many activities of daily living and people are slow to give up 
walking. Problems with walking can be treated with physical therapy, but the process is 
slow. So walking declines slowly and returns slowly with therapy.  We suggest that this 
makes mobility a better predictor for long term HRQOL. 
As noted coping was also a significant predictor of HRQOL. While coping was 
measured by only a single item these results are consistent with studies that demonstrate 
coping skills are vital in adjusting to one’s disease limitations (Hesselink, Penninx, 
Schlösser, Wijnhoven, van der Windt, Kriegsman, & van Eijk, 2004; Ketelaars et al., 
1996). Active coping skills have been shown to predict health-related quality of life in 
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those with chronic illnesses (Gibson, Rueda, Rourke,  Bekele,  Gardner,  Fente,  & Hart, 
2011; Myaskovsky et al., 2003).  Previous studies have demonstrated correlations 
between age and coping with HRQOL in those with COPD especially with very severe 
disease (Ferrer et al, 1997; Hesselink, Penninx, Schlösser, Wijnhoven, van der Windt, 
Kriegsman, & van EijkSource, 2004; McSweeny, Grant, Heaton, Adams, & Timms 1982; 
Stahl et al., 2005).  This study supports those same findings.  The results of this study are 
consistent with previous research.  
It is well known that COPD patients have a less active lifestyle compared to 
healthy elderly persons (Pitta, Troosters, Probst, Decramer, & Gosselink, 2005; van 
Gestel et al., 2012).  In a recent study, frailty in COPD was significantly associated with a 
reduction in activities of daily living (Park, Richardson, Holleman, & Larson, 2013). 
Decreased physical activity in COPD has also been correlated with a decreased HRQOL 
(Pitta, Troosters, Probst, Decramer, & Gosselink, 2005).    
There is conflicting evidence to substantiate socioeconomic status as a predictor 
of HRQOL (McSweeny, Grant, Heaton, Adams, & Timms, 1982; Miravitlles, Naberan, 
Cantoni, & Azpeitia, 2011). We did not find income to be a significant predictor of 
HRQOL and while education was significant it was only significant at two time points (6 
months post randomization and 24 post randomization). Surprisingly, this finding was not 
seen at baseline. It is difficult to explain the reason for this as education and 
socioeconomic (or income) status are related.  Generally as one’s education levels 
increase so does socioeconomic status. Lower education levels have long been associated 
with a lower quality of life (Jackson, Suzuki, Coultas, Singh, & Bae, 2013; Prigatano, 
Wright, & Levin, 1984). 
   
72 
 
Unexpectedly this study did not find anxiety to be a predictor of HRQOL.  We do 
not know the disease duration of each person but since this study consisted of those with 
severe COPD it is conceivable that they have had their disease for some time and were 
better able to cope with the anxiety frequently seen with dyspnea (Mauer, et al.,  2008; 
Lansing, Gracely, & Banzett, 2009).  As disease progression occurs over time, this group 
may have adopted strategies to help in disease management thereby decreasing their 
anxiety.  It is also plausible that this group had less anxiety because they were enrolled in 
an intervention trial and had just completed pulmonary rehabilitation. Patients had easy 
access to study staff by either in-person visits or phone contacts they may have felt less 
anxiety just by virtue of the close monitoring that comes with being a study participant. 
As expected those individuals with more frailty had decreased survival time over 
those with less frailty.  The relationship between frailty and mortality has been studied 
extensively and these results are similar to others demonstrating that people with frailty 
have an increased mortality (Buchman, Wilson, Bienias, & Bennett, 2009; Ensurd et al.; 
2008; Fried et al., 2001; Mitnitski, Song & Rockwood, 2004).  .   
Our original hypothesis that frailty would be associated with increased health care 
utilization was not substantiated over 36 months of the study.  The mean number of days 
for an overnight stay was 1.24 (SD=6.21) over 36 months of the study. The mean number 
of visits to an emergency room or health care provider was 2.69 (SD=2.82) over 36 
months of the study.  Our results seem low given the severity of the lung disease. There 
may be inaccuracies in the data set due to the method in which the health care utilization 
question was prefaced.  That is, as noted in the methods section, patients were asked to 
report health care utilization for only 3 months out of every year.  Health care utilization 
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could have occurred but not been captured with this methodology.  It is also recognized 
that clinical practice may vary across the multiple sites for data collection. Specifically 
deciding when a person should be admitted to a health care facility, see a health care 
provider, or have a health care provider sent to their home can be quite varied. This is an 
independent decision of the health care providers and there are no universal guidelines as 
to how to best manage each person. Another explanation for this finding may be due to 
the number of comorbidities.  Even though we do not have data about patients’ 
comorbidities, we can assume that they were in a relatively healthy state (despite their 
chronic disease) because they were eligible to be randomized to the surgical arm of the 
study. 
The mean number of home visits by a health care provider or health care service 
worker was 4.61 (9.75) over 36 months of the study. We did find an increased use of 
home health care services at each time point. Health care utilization, such as emergency 
room visits, hospital admissions, and physician visits are all increased with frail 
individuals (Kiely, Cupples, & Lipsitz, 2009; Romero-Ortuno, Walsh, Lawlor, & Kenny, 
2010).   
 It is interesting to note that disease severity was a better predictor of home visits 
than frailty indicators.  As pulmonary status deteriorated more home care visits were 
required. This is not a surprising finding and it is recognized that predictors associated 
with the use of health services require careful interpretation due to the variability of 
health care institutions and providers across the country.  It is difficult to tease out the 
effects of frailty and practice patterns from this study. 
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  Clinical Implications 
  In Gobbens’ (2010) conceptual model there are theoretical time intervals along 
the model’s continuum that interventions could be done to prevent frailty, delay frailty, 
diminish frailty and decrease the adverse outcomes such as death. Further work is needed 
in designing studies with targeted interventions at appropriate time intervals to achieve 
these goals.  
Certainly, mobility is an important component of doing basic ADL’s and thus is 
an important construct to focus on with this population. At present, one method of 
creating a more active lifestyle is pulmonary rehabilitation.  Pulmonary rehabilitation has 
been proven to relieve fatigue and dyspnea, improve mental capacity, and increase 
patients’ control over their disease (Lacasse, Martin, Lasserson, & Goldenstein, 2007). It 
improves symptoms and exercise capacity thereby improving health-related quality of life 
(Fabbri & Hurd, 2003; GOLD 2009; Nici et al., 2006).  Increased muscle strength, gait 
speed, and stair climbing have been observed in frail COPD patients who have 
participated in a structured pulmonary rehabilitation program (Fiatarone et al., 1994). 
Increased endurance can allow for an increased independence in activities of daily living 
and a greater sense of satisfaction that coincides with this accomplishment. Clinicians 
should encourage pulmonary rehabilitation as it results in increased physical activity and 
endurance thereby preventing or delaying frailty 
Given that coping was the other significant frailty psychological indicator for 
HRQOL, it should be retained as part of the frailty model. Though coping in this study, 
was operationalized as feeling like one had control over events in their life, the 
importance of it as a predictor of long term HRQOL is note-worthy.  A lower sense of 
   
75 
 
control reflects a sense of uncertainty about the future and may be an important indicator 
of the long term outlook for an individual. Adequate coping can serve as protective 
factors for patients struggling with chronic illness. 
As evidenced by the findings optimization of health-related quality of life is a 
relevant goal for care of patients with COPD. Future studies should be done to determine 
if improving the other significant findings (endurance, balance, and depression) would 
improve HRQOL. 
From a clinical perspective, meeting the needs of this chronically ill disease 
population may necessitate increasing home visits as this could play a role in decreasing 
emergency room visits, decreasing COPD exacerbations, and hospital overnight visits. 
Additionally, since mobility and coping were significant indicators over time of HRQOL 
it could useful to have objective measures of mobility and coping done by clinicians at a 
clinic visit to assess for difficulties or declines in these indicators. 
Limitations 
 A major limitation is that it is a secondary data analysis. All the indicators one 
would like to include in a study may not be available and the methodology in which they 
were collected may be different than if the study was being done as a primary study. The 
sample size was large but there was little heterogeneity in the disease state since they 
were all severe in their disease classification.  Future studies should aim to validate the 
prospective frailty indicators in COPD and include those of varied disease severity.   
Many of the indicators used in this study were self-reported. A self-report 
instrument with excessive length or difficult comprehension may be a limiting factor with 
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older people. This may lead to errors and may have caused bias during the data collection 
process.  
 While this study had longitudinal data, the indicators of anxiety and depression 
were only obtained at baseline and the scores replicated at subsequent time points. The 
scores for these indicators may have changed over the course of the study though this was 
a group of severe COPD people already receiving maximal medical therapies and since 
anxiety and depression are associated with respiratory symptoms it is rather unlikely that 
they would improve since the chronic nature of the disease itself precludes improvement 
without interventions (Ben-Shlomo & Kuh 2002). 
Conclusion 
 In summary, though this study was not aimed at developing another frailty model 
it does provide information on additional frailty indicators to consider in this population. 
Frailty is a challenging concept to define and it beckons us to collectively consider the 
best methodology to collect accurate data in not only defining the disease but potential 
interventions to prevent it. The results of this study indicate associations between frailty 
and the outcomes of HRQOL and death in those with severe COPD.  As frailty exerts a 
substantial impact on HRQoL and mortality, our study has important implications for 
future interventions aimed at preventing or delaying the development of frailty among 
older adults.






A. Frailty Criteria used to Define Frailty (Fried 2001) 
• Weight loss: ―In the last year, have you lost more than 10 pounds unintentionally (i.e., 
not due to dieting or exercise)?‖ If yes, then frail for weight loss criterion. At follow-up, 
weight loss was calculated as: (Weight in previous year – current measured 
weight)/(weight in previous year) = K. If K ≥ 0.05 and the subject does not report that 
he/she was trying to lose weight (i.e., unintentional weight loss of at least 5% of previous 
year's body weight), then frail for weight loss = Yes.  
 
• Exhaustion: Using the CES–D Depression Scale, the following two statements are 
read. (a) I felt that everything I did was an effort; (b) I could not get going. The question 
is asked ―How often in the last week did you feel this way?‖ 0 = rarely or none of the 
time (<1 day), 1 = some or a little of the time (1–2 days), 2 = a moderate amount of the 
time (3–4 days), or 3 = most of the time. Subjects answering ―2‖ or ―3‖ to either of these 
questions are categorized as frail by the exhaustion criterion.  
 
• Physical Activity: Based on the short version of the Minnesota Leisure Time Activity 
questionnaire, asking about walking, chores (moderately strenuous), mowing the lawn, 
raking, gardening, hiking, jogging, biking, exercise cycling, dancing, aerobics, bowling, 
golf, singles tennis, doubles tennis, racquetball, calisthenics, swimming. Kcals per week 
expended are calculated using standardized algorithm. This variable is stratified by 
gender.  
Men: Those with Kcals of physical activity per week <383 are frail.  
Women: Those with Kcals per week <270 are frail.  
 
• Walk Time, stratified by gender and height (gender-specific cutoff a medium height).  
Men Cutoff for Time to Walk 15 feet criterion 
for frailty 
Height ≤ 173 cm ≥7 seconds 
Height > 173 cm ≥6 seconds 
Women  
Height ≤ 159 cm ≥7 seconds 
Height > 159 cm ≥6 seconds 




• Grip Strength, stratified by gender and body mass index (BMI) quartiles:  
Men Cutoff for grip strength (Kg) criterion for 
frailty 
BMI ≤ 24 ≤29 
BMI 24.1–26 ≤30 
BMI 26.1–28 ≤30 
BMI > 28 ≤32 
Women  
BMI ≤ 23 ≤17 
BMI 23.1–26 ≤17.3 
BMI 26.1–29 ≤18 
BMI > 29 ≤21 
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B. Trail Making Part A 
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C. Beck Depression Inventory 
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Coefficients (β), t-values, and p-values for Demographic Characteristics and the Frailty 
Indicators as Predictor of Health Related Quality of Life in Final Model at 6 months post 
randomization (n=496) 
Indicators          B                β        t-value        p-value 
(Intercept) 60.399   9.217 .000 
Age  -.173 -.124 -3.097 .002 
Race 1.052 .017 .450 .653 
Income -.057 -.004 -.089 .929 
Marital status .938 .032 .732 .465 
Education -1.552 -.087 -2.110 .035 
Gender 4.466 .152 3.492 .001 
Nutrition -.202 -.053 -1.341 .181 
Endurance -.121 -.197 -4.472 <.001 
Balance 4.935 .090 2.306 .022 
Mobility 10.463 .334 8.207 <.001 
Vision -2.032 -.037 -.973 .331 
Hearing 2.327 .072 1.861 .064 
Coping 7.441 .226 5.474 <.001 
Anxiety .020 .015 .274 .784 
Depression .500 .209 3.853 <.001 
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Table F2.  
  












.034 2.374     .029* 
Model 2 
 
.319 28.202  <.001** 
Model 3 .438 28.260  <.001**. 
**p < .001, *p < .05 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, nutrition, 
endurance, balance, mobility, vision, and hearing. 
c. Model 3 includes: age, gender, race, marital status, education, income, nutrition, 



















Coefficients (β), t-values, and p-values for Demographic Characteristics and the Frailty 
Indicators as Predictor of Health Related Quality of Life in Final Model at 12 months 
post randomization (n=428) 
Indicators          B              β       t-value        p-value 
(Intercept) 64.309   8.375 .000 
Age  -.184 -.134 -2.775 .006 
Race 1.934 .032 .698 .486 
Income -.056 -.004 -.074 .941 
Marital status -.338 -.012 -.222 .824 
Education -1.640 -.094 -1.893 .059 
Gender 3.129 .108 2.007 .046 
Nutrition -.251 -.066 -1.412 .159 
Endurance -.111 -.188 -3.448 .001 
Balance 5.859 .118 2.563 .011 
Mobility 10.264 .307 6.180 <.001 
Vision -4.421 -.088 -1.923 .055 
Hearing 2.728 .087 1.856 .064 
Coping 7.818 .237 4.860 <.001 
Cognition .044 .049 1.021 .308 
Anxiety -.061 -.046 -.722 .471 
Depression .444 .188 2.956 .003 
 




Table F4.  
 












.042   2.242    .039* 
Model 2 
 
.307 19.266  <.001** 
Model 3 .399 11.370  <.001** 
**p < .001, *p < .05 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, nutrition, 
endurance, balance, mobility, vision, and hearing. 
c. Model 3 includes: age, gender, race, marital status, education, income, nutrition, 


















Coefficients (β), t-values, and p-values for Demographic Characteristics and the Frailty 
Indicators Predictor of Health Related Quality of Life in Final Model at 24 months post 
randomization (n=349) 
Indicators         B               β        t-value        p-value 
(Intercept) 52.007   5.194 .000 
Age  -.051 -.036 -.606 .545 
Race 5.460 .089 1.560 .120 
Income .024 .002 .026 .979 
Marital status 1.033 .034 .543 .587 
Education -2.406 -.134 -2.263 .025 
Gender 3.017 .101 1.618 .107 
Nutrition -.126 -.032 -.560 .576 
Endurance -.107 -.172 -2.643 .009 
Balance 1.815 .039 .688 .492 
Mobility 11.209 .340 5.875 <.001 
Vision 2.099 .040 .719 .473 
Hearing 1.127 .036 .629 .530 
Coping 8.503 .254 4.277 <.001 
Cognition .039 .039 .673 .502 
Anxiety -.164 -.120 -1.519 .130 
Depression .579 .239 3.077 .002 
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Table F6.   
 












.033   1.298    .259 
Model 2 
 
.258 11.317  <.001** 
Model 3 .356 8.383  <.001** 
**p < .001, *p < .05 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, nutrition, 
endurance, balance, mobility, vision, and hearing. 
c. Model 3 includes: age, gender, race, marital status, education, income, nutrition, 
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Table. F7  
Coefficients (β), t-values, and p-values for Demographic Characteristics and the Frailty 
Indicators Predictor of Health Related Quality of Life in Final Model at 36 months post 
randomization (n=215) 
Indicators          B                  β         t-value        p-value 
(Intercept) 28.187   2.190 .030 
Age  .165 .112 1.547 .124 
Race 5.245 .082 1.193 .235 
Income -.803 -.054 -.675 .501 
Marital status -.324 -.010 -.135 .893 
Education -2.280 -.122 -1.650 .102 
Gender 4.756 .154 1.934 .055 
Nutrition .061 .016 .215 .830 
Endurance -.094 -.155 -1.864 .065 
Balance -.286 -.007 -.095 .924 
Mobility 13.969 .421 5.560 <.001 
Vision .138 .003 .047 .963 
Hearing -1.786 -.055 -.768 .444 
Coping 9.963 .302 4.056 <.001 
Cognition .112 .113 1.630 .106 
Anxiety -.013 -.009 -.096 .923 
Depression .201 .080 .824 .412 
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.032 .714    .639 
Model 2 
 
.367 11.052  <.001** 
Model 3 .473 6.057  <.001** 
**p < .001, *p < .05 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, nutrition, 
endurance, balance, mobility, vision, and hearing. 
c. Model 3 includes: age, gender, race, marital status, education, income, nutrition, 
endurance, balance, mobility, vision, hearing, cognition, depression, anxiety and coping. 
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F.   
Table G1.   
Model Summary for Demographic Characteristics, Clinical Characteristics, and  Frailty 
Indicators as predictors of number of overnight stays (hospital, acute care facility, 
rehabilitation hospital, nursing home, or non-acute care facility) at 6 months post 
randomization (n=401)  
Model R
2





      p 
Model 1 
 
.009   .615 .718 
Model 2 
 
.032 1.917 .090 
Model 3 .041   .658 .683 
Model 4 .049 1.131 .336 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, anxiety, 
and depression. 
PBD = post bronchodilator, PY=pack years, RA = room air 
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Table G2.  
Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of overnight stays 
(hospital, acute care facility, rehabilitation hospital, nursing home, or non-acute care 
facility) in final model at 6 months post randomization (n=401) 
Indicators          B                  β         t-value        p-value 
(Intercept) 1.814   2.890 .004 
Age  -.009 -.091 -1.436 .152 
Race .126 .052 1.010 .313 
Income -.004 -.007 -.119 .906 
Marital status -.033 -.028 -.487 .627 
Education -.035 -.050 -.899 .369 
Gender .069 .059 .839 .402 
FEV1 (PBD) -.007 -.088 -1.175 .241 
TLC (PBD) .003 .086 .942 .347 
RV (PBD) -.003 -.239 -2.052 .041 
PaO2 (RA) -.004 -.072 -1.378 .169 
Smoking (PY) -.001 -.053 -1.007 .315 
Nutrition -.009 -.056 -1.039 .299 
Endurance -.003 -.104 -1.527 .128 
Balance .043 .019 .379 .705 
Mobility -.034 -.027 -.512 .609 
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Vision -.045 -.020 -.404 .686 
Hearing .033 .025 .493 .622 
Coping .026 .019 .357 .722 
Anxiety -.006 -.111 -1.563 .119 
Depression .011 .119 1.669 .096 
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Table G3.   
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of number of overnight stays (hospital, acute care facility, 









      p 
Model 1 
 
.034 1.806 .098 
Model 2 
 
.057 1.241 .285 
Model 3 .078 1.085 .372 
Model 4 .080   .190 .943 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), and RV % predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD) vision, mobility, balance, hearing, nutrition, and 
endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD) vision, mobility, balance, hearing, nutrition, 
endurance, coping, cognition, anxiety, and depression. 











Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of overnight stays 
(hospital, acute care facility, rehabilitation hospital, nursing home, or non-acute care 
facility) in final model at 12 months post randomization (n=289) 
Indicators           B               β      t-value       p-value 
(Intercept) 1.710   1.987 .048 
Age  -.006 -.051 -.693 .489 
Race -.177 -.059 -1.003 .316 
Income .048 .068 .999 .319 
Marital status -.039 -.027 -.404 .687 
Education -.107 -.122 -1.932 .054 
Gender -.074 -.052 -.570 .569 
FEV1 (PBD) -.005 -.060 -.693 .489 
TLC (PBD) -.003 -.061 -.554 .580 
RV (PBD) .000 -.025 -.168 .867 
PaO2 (RA) -.005 -.087 -1.265 .207 
DLCO (PBD) 
 
.005 .072 .984 .326 
Smoking (PY) -.001 -.065 -1.075 .283 
Nutrition .008 .042 .663 .508 
Endurance -.003 -.108 -1.223 .222 
Balance .279 .113 1.942 .053 
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Mobility -.046 -.027 -.434 .664 
Vision .066 .026 .452 .652 
Hearing .069 .044 .752 .453 
Coping -.022 -.014 -.220 .826 
Cognition .002 .045 .737 .461 
Anxiety .002 .029 .360 .719 
Depression -.004 -.031 -.390 .697 
PBD = post bronchodilator, PY=pack years, RA = room air 
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Table G5.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of number of overnight stays (hospital, acute care facility, 









      p 
Model 1 
 
.019  .751 .609 
Model 2 
 
.056 1.751 .124 
Model 3 .127 2.977 .008 
Model 4 .136  .525 .718 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, 
cognition, anxiety, and depression. 












Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and  Frailty Indicators as predictors of number of overnight stays 
(hospital, acute care facility, rehabilitation hospital, nursing home, or non-acute care 
facility) in final model at 24 months post randomization (n=223) 
Indicators          B                β        t-value        p-value 
(Intercept) 2.376   2.565 .011 
Age  -.019 -.166 -1.950 .053 
Race -.047 -.016 -.236 .814 
Income -.063 -.093 -1.205 .230 
Marital status .138 .098 1.304 .194 
Education .047 .056 .792 .429 
Gender -.091 -.065 -.674 .501 
FEV1 (PBD) .000 .003 .028 .977 
TLC (PBD) -.004 -.094 -.722 .471 
RV (PBD) .000 -.009 -.053 .958 
PaO2 (RA) -.003 -.039 -.545 .586 
Smoking (PY) .003 .136 1.974 .050 
Nutrition -.010 -.055 -.798 .426 
Endurance -.003 -.102 -1.137 .257 
Balance .512 .232 3.412 .001 
Mobility -.064 -.041 -.594 .553 
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Vision .285 .115 1.743 .083 
Hearing .079 .053 .781 .436 
Coping -.099 -.063 -.887 .376 
Cognition .002 .045 .647 .518 
Anxiety .003 .041 .437 .663 
Depression -.009 -.079 -.867 .387 
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Table G7.   
Model Summary for Demographic Characteristics, Clinical Characteristics, and  Frailty 
Indicators as predictors of number of overnight stays (hospital, acute care facility, 









      p 
Model 1 
 
.042 .927 .478 
Model 2 
 
.068 .707 .619 
Model 3 .102 .727 .629 
Model 4 .132 .969 .427 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, 
cognition, anxiety, and depression. 


















Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of overnight stays 
(hospital, acute care facility, rehabilitation hospital, nursing home, or non-acute care 
facility) in final model at 36 months post randomization (n=126) 
Indicators         B                 β         t-value        p-value 
(Intercept) 1.896   2.024 .045 
Age  -.016 -.195 -1.790 .076 
Race .186 .093 .991 .324 
Income .065 .141 1.314 .191 
Marital status -.123 -.127 -1.232 .220 
Education -.026 -.044 -.438 .662 
Gender -.004 -.004 -.033 .974 
FEV1 (PBD) .007 .128 .998 .320 
TLC (PBD) -.006 -.198 -1.230 .221 
RV (PBD) .001 .068 .342 .733 
PaO2 (RA) -.002 -.045 -.455 .650 
Smoking (PY) .000 -.025 -.258 .797 
Nutrition -.016 -.133 -1.276 .204 
Endurance .001 .077 .625 .533 
Balance -.003 -.002 -.022 .983 
Mobility .016 .015 .146 .884 
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Vision -.006 -.004 -.044 .965 
Hearing .119 .118 1.193 .235 
Coping .149 .145 1.439 .153 
Cognition 000 -.002 -.018 .986 
Anxiety .001 .013 .101 .920 
Depression -.014 -.174 -1.325 .188 
PBD = post bronchodilator, PY=pack years, RA = room air 
  





Model Summary for Demographic Characteristics, Clinical Characteristics, and  Frailty 
Indicators as predictors of number of visits to an emergency room (including triage and 
urgent care) or visits to a health care provider (physician, physician’s assistant, nurse) at 
6 months post randomization (n=401) 
Model R
2





   p 
Model 1 
 
.008   .581 .745 
Model 2 
 
.023 1.166 .325 
Model 3 .070 3.376 .003 
Model 4 .073  .495 .686 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, anxiety, 
and depression. 










Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of visits to an emergency 
room (including triage and urgent care) or visits to a health care provider (physician, 
physician’s assistant, nurse) in final model at 6 months post randomization (n=401) 
Indicators           B                β        t-value       p-value 
(Intercept) .985   1.828 .068 
Age  -.005 -.055 -.889 .374 
Race .021 .010 .197 .844 
Income .030 .061 1.038 .300 
Marital status -.064 -.062 -1.102 .271 
Education -.025 -.040 -.741 .459 
Gender .053 .051 .745 .457 
FEV1 (PBD) .011 .171 2.322 .021 
TLC (PBD) -.004 -.125 -1.397 .163 
RV (PBD) .001 .145 1.264 .207 
PaO2 (RA) .002 .048 .924 .356 
Smoking (PY) .001 .058 1.125 .261 
Nutrition -.001 -.008 -.152 .880 
Endurance -.005 -.231 -3.436 .001 
Balance .097 .050 .998 .319 
Mobility .096 .088 1.663 .097 
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Vision .029 .015 .303 .762 
Hearing .023 .021 .406 .685 
Coping -.028 -.024 -.447 .655 
Anxiety .004 .082 1.177 .240 
Depression -.004 -.046 -.654 .513 
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Table H3.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of number of visits to an emergency room (including triage and 
urgent care) or visits to a health care provider (physician, physician’s assistant, nurse) at 
12 months post randomization (n=289) 
Model R
2





  p 
Model 1 
 
.022 1.161 .327 
Model 2 
 
.047 1.331 .243 
Model 3 .060   .691 .657 
Model 4 .069   .638 .636 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), and RV % predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD) vision, mobility, balance, hearing, nutrition, and 
endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD) vision, mobility, balance, hearing, nutrition, 
endurance, coping, cognition, anxiety, and depression. 
PBD = post bronchodilator, PY=pack years, RA = room air  
 
  




Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of visits to an emergency 
room (including triage and urgent care) or visits to a health care provider (physician, 
physician’s assistant, nurse) in final model at 12 months post randomization (n=289) 
Indicators           B                 β         t-value       p-value 
(Intercept) 1.161   1.791 .074 
Age  .001 .006 .080 .936 
Race -.047 -.021 -.357 .721 
Income -.078 -.150 -2.172 .031 
Marital status .137 .126 1.892 .060 
Education .038 .058 .904 .367 
Gender -.024 -.022 -.239 .811 
FEV1 (PBD) .006 .102 1.167 .244 
TLC (PBD) -.002 -.070 -.630 .529 
RV (PBD) .000 .009 .061 .951 
PaO2 (RA) -.007 -.143 -2.069 .039 
DLCO (PBD) 
 
.004 .072 .982 .327 
Smoking (PY) .000 -.017 -.282 .778 
Nutrition .004 .028 .436 .663 
Endurance -.001 -.036 -.412 .681 
Balance .101 .055 .934 .351 
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Mobility .047 .038 .594 .553 
Vision -.033 -.018 -.302 .763 
Hearing .077 .066 1.115 .266 
Coping -.039 -.032 -.510 .610 
Cognition .002 .072 1.181 .239 
Anxiety .001 .027 .338 .736 
Depression .003 .039 .488 .626 
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Table H5.   
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of number of visits to an emergency room (including triage and 
urgent care) or visits to a health care provider (physician, physician’s assistant, nurse) at 
24 months post randomization (n=223) 
Model R
2





  p 
Model 1 
 
.012 .454 .842 
Model 2 
 
.027 .711 .615 
Model 3 .052 .964 .450 
Model 4 .064 .703 .591 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, 
cognition, anxiety, and depression. 
PBD = post bronchodilator, PY=pack years, RA = room air  
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Table H6.  
Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of visits to an emergency 
room (including triage and urgent care) or visits to a health care provider (physician, 
physician’s assistant, nurse) in final model at 24 months post randomization (n=223) 
Indicators          B                 β         t-value       p-value 
(Intercept) 1.173   1.518 .130 
Age  -.001 -.014 -.154 .878 
Race -.040 -.017 -.241 .810 
Income .022 .041 .512 .609 
Marital status .034 .030 .387 .699 
Education .003 .005 .068 .946 
Gender -.027 -.024 -.238 .812 
FEV1 (PBD) .001 .020 .197 .844 
TLC (PBD) -.001 -.015 -.110 .912 
RV (PBD) -.001 -.114 -.640 .523 
PaO2 (RA) .000 -.005 -.067 .947 
Smoking (PY) .001 .041 .572 .568 
Nutrition .003 .022 .302 .763 
Endurance -.002 -.090 -.958 .339 
Balance .139 .079 1.112 .268 
Mobility -.017 -.013 -.187 .852 
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Vision .151 .076 1.111 .268 
Hearing .060 .051 .719 .473 
Coping .101 .080 1.088 .278 
Cognition .003 .082 1.138 .256 
Anxiety -.003 -.049 -.510 .611 
Depression .003 .030 .314 .754 
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Table H7.   
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of number of visits to an emergency room (including triage and 
urgent care) or visits to a health care provider (physician, physician’s assistant, nurse) at 
36 months post randomization (n=126) 
Model R
2





   p 
Model 1 
 
.014   .313 .929 
Model 2 
 
.059 1.152 .337 
Model 3 .086   .578 .747 
Model 4 .117 1.019 .401 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, 
cognition, anxiety, and depression. 












Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of visits to an emergency 
room (including triage and urgent care) or visits to a health care provider (physician, 
physician’s assistant, nurse) in final model at 36 months post randomization (n=126) 
Indicators          B                 β         t-value        p-value 
(Intercept) 1.292   1.366 .175 
Age  -.003 -.032 -.293 .770 
Race .058 .029 .307 .759 
Income .033 .072 .666 .507 
Marital status -.109 -.112 -1.078 .283 
Education -.034 -.058 -.577 .565 
Gender .025 .026 .207 .837 
FEV1 (PBD) .008 .157 1.215 .227 
TLC (PBD) -.003 -.083 -.515 .608 
RV (PBD) .000 .003 .017 .986 
PaO2 (RA) .006 .142 1.428 .156 
Smoking (PY) .000 -.017 -.176 .860 
Nutrition -.006 -.053 -.506 .614 
Endurance -.003 -.151 -1.211 .228 
Balance .029 .022 .225 .823 
Mobility .032 .031 .298 .766 
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Vision -.054 -.040 -.418 .676 
Hearing .036 .036 .361 .719 
Coping .076 .074 .724 .471 
Cognition .000 -.015 -.159 .874 
Anxiety -.009 -.210 -1.632 .106 
Depression .017 .216 1.637 .104 
PBD = post bronchodilator, PY=pack years, RA = room air 
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H.   
Table I1.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and  Frailty 
Indicators as predictors of number of home visits by a health care provider (home health 
agency nurse, physical therapist, occupational therapist) or health care service worker 
(aide/attendant, health equipment) at 6 months post randomization (n=401) 
Model R
2





      p 
Model 1 
 
.004     .266 .953 
Model 2 
 
.146 13.476 <.001 
Model 3 .150     .286 .944 
Model 4 .155     .812 .488 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, anxiety, 
and depression. 
 










Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of home visits by a health 
care provider  (home health agency nurse, physical therapist, occupational therapist) or 
health care service worker (aide/attendant, health equipment technician) in final model 
at 6 months post randomization (n=401) 
Indicators          B                β         t-value        p-value 
(Intercept) 3.144   2.762 .006 
Age  .001 .005 .091 .928 
Race -.190 -.040 -.841 .401 
Income .002 .001 .025 .980 
Marital status .024 .011 .198 .843 
Education .108 .079 1.507 .133 
Gender -.143 -.063 -.956 .340 
FEV1 (PBD) -.020 -.137 -1.949 .052 
TLC (PBD) .000 .006 .065 .949 
RV (PBD) .000 -.001 -.013 .989 
PaO2 (RA) -.032 -.305 -6.174 <.001 
Smoking (PY) .004 .120 2.442 .015 
Nutrition -.002 -.007 -.142 .887 
Endurance -.002 -.038 -.587 .557 
Balance .199 .047 .974 .331 
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Mobility .076 .032 .624 .533 
Vision -.011 -.003 -.057 .955 
Hearing .032 .013 .264 .792 
Coping -.133 -.052 -1.014 .311 
Anxiety .007 .069 1.031 .303 
Depression -.012 -.067 -1.006 .315 





















Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of number of  home visits by a health care provider (home health 
agency nurse, physical therapist, occupational therapist) or health care service worker 
(aide/attendant, health equipment technician) at 12 months post randomization (n=289) 
Model R
2





      p 
Model 1 
 
.007     .377 .893 
Model 2 
 
.262 17.408 <.001 
Model 3 .281   1.266 .273 
Model 4 .292   1.123 .346 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), and RV % predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD) vision, mobility, balance, hearing, nutrition, and 
endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), DLCO % predicted (PDB), smoking history (PY), PaO2 (RA), FEV1 % 
predicted (PBD), RV % predicted (PBD) vision, mobility, balance, hearing, nutrition, 
endurance, coping, cognition, anxiety, and depression. 
PBD = post bronchodilator, PY=pack years, RA = room air  
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Table I4.  
Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of home visits by a health 
care provider  (home health agency nurse, physical therapist, occupational therapist) or 
health care service worker (aide/attendant, health equipment technician) in final model 
at 12 months post randomization (n=289) 
Indicators           B                   β         t-value        p-value 
(Intercept) 2.920   2.443 .015 
Age  -.003 -.018 -.269 .788 
Race -.157 -.033 -.643 .521 
Income .061 .055 .921 .358 
Marital status .014 .006 .103 .918 
Education -.049 -.035 -.638 .524 
Gender .191 .083 1.052 .294 
FEV1 (PBD) -.014 -.108 -1.427 .155 
TLC (PBD) .020 .269 2.776 .006 
RV (PBD) -.005 -.223 -1.732 .084 
PaO2 (RA) -.033 -.334 -5.561 <.001 
DLCO (PBD) 
 
-.020 -.179 -2.791 .006 
Smoking (PY) .001 .029 .543 .587 
Nutrition .022 .074 1.322 .187 
Endurance -.007 -.146 -1.888 .060 
   
140 
 
Balance .084 .022 .422 .674 
Mobility .018 .007 .123 .902 
Vision .032 .008 .157 .875 
Hearing .199 .081 1.556 .121 
Coping -.045 -.017 -.317 .751 
Cognition -.006 -.088 -1.646 .101 
Anxiety -.008 -.073 -1.027 .305 
Depression .006 .033 .476 .635 
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Table I5.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and Frailty 
Indicators as predictors of number of home visits by a health care provider (home health 
agency nurse, physical therapist, occupational therapist) or health care service worker 
(aide/attendant, health equipment) at 24 months post randomization (n=223) 
Model R
2





      p 
Model 1 
 
.019     .726 .629 
Model 2 
 
.219 11.553 <.001 
Model 3 .276   2.844 .011 
Model 4 .287     .878 .478 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, 
cognition, anxiety, and depression. 
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Table I6.  
Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of home visits by a health 
care provider (home health agency nurse, physical therapist, occupational therapist) or 
health care service worker (aide/attendant, health equipment technician) in final model 
at 24 months post randomization (n=223) 
Indicators             B                   β         t-value        p-value 
(Intercept) 5.215   4.554 .000 
Age  -.014 -.125 -1.644 .102 
Race .340 .072 1.153 .250 
Income .074 .067 .964 .336 
Marital status .017 .007 .107 .915 
Education -.126 -.091 -1.440 .151 
Gender .165 .072 .830 .408 
FEV1 (PBD) -.015 -.121 -1.378 .170 
TLC (PBD) .010 .132 1.115 .266 
RV (PBD) -.003 -.133 -.855 .394 
PaO2 (RA) -.036 -.335 -5.197 <.001 
Smoking (PY) .000 -.011 -.175 .861 
Nutrition -.042 -.140 -2.243 .026 
Endurance -.010 -.209 -2.549 .011 
Balance .233 .065 1.051 .294 
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Mobility -.112 -.044 -.706 .481 
Vision .462 .115 1.917 .057 
Hearing -.103 -.043 -.687 .493 
Coping -.069 -.027 -.422 .674 
Cognition .004 .055 .904 .367 
Anxiety -.008 -.080 -.953 .342 
Depression .023 .124 1.495 .136 
















   
144 
 
Table I7.  
Model Summary for Demographic Characteristics, Clinical Characteristics, and  Frailty 
Indicators as predictors of number of  home visits by a health care provider (home health 
agency nurse, physical therapist, occupational therapist) or health care service worker 
(aide/attendant, health equipment) at 36 months post randomization (n=126) 
Model R
2





      p 
Model 1 
 
.004   .083 .998 
Model 2 
 
.261 8.537 <.001 
Model 3 .379 3.716 .002 
Model 4 .385   .288 .885 
a. Model 1 includes: age, gender, race, marital status, education, and income. 
b. Model 2 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), and RV % 
predicted (PBD). 
c. Model 3 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, and endurance. 
d. Model 4 includes: age, gender, race, marital status, education, income, TLC % 
predicted (PBD), smoking history (PY), PaO2 (RA), FEV1 % predicted (PBD), RV % 
predicted (PBD) vision, mobility, balance, hearing, nutrition, endurance, coping, 
cognition, anxiety, and depression. 












Coefficients (β), t-values, and p-values for Demographic Characteristics, Clinical 
Characteristics, and Frailty Indicators as predictors of number of home visits by a health 
care provider  (home health agency nurse, physical therapist, occupational therapist) or 
health care service worker (aide/attendant, health equipment technician) in final model 
at 36 months post randomization (n=126) 
Indicators           B                 β         t-value        p-value 
(Intercept) 5.792   3.070 .003 
Age  -.022 -.113 -1.231 .221 
Race .289 .061 .766 .445 
Income -.002 -.002 -.019 .985 
Marital status .120 .052 .598 .551 
Education -.048 -.034 -.405 .686 
Gender .520 .225 2.136 .035 
FEV1 (PBD) -.026 -.212 -1.961 .052 
TLC (PBD) .018 .242 1.790 .076 
RV (PBD) -.010 -.396 -2.365 .020 
PaO2 (RA) -.034 -.350 -4.225 <.001 
Smoking (PY) -.001 -.026 -.317 .752 
Nutrition -.012 -.043 -.485 .629 
Endurance -.017 -.376 -3.628 <.001 
Balance .403 .126 1.554 .123 
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Mobility -.015 -.006 -.068 .946 
Vision .163 .051 .637 .526 
Hearing .071 .029 .354 .724 
Coping .134 .055 .643 .522 
Cognition .000 -.006 -.074 .941 
Anxiety -.009 -.086 -.803 .423 
Depression .002 .012 .106 .916 
PBD = post bronchodilator, PY=pack years, RA = room air 
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